no	Field Name	Datasource	Version	Description	value_example (separated by ';')
1	chrom	ENSEMBLgene	v99	name of the chromosome or scaffold; chromosome names without a 'chr'	1; 2; 3; 4; 5; 6; 7; X; 8; 9
2	spos	ENSEMBLgene	v99	start position	11869; 14404; 17369; 29554; 30366; 34554; 52473; 57598; 65419; 89295
3	epos	ENSEMBLgene	v99	end position	14409; 29570; 17436; 31109; 30503; 36081; 53312; 64116; 71585; 133723
4	ensgid	ENSEMBLgene	v99	The stable identifier for the gene	ENSG00000223972; ENSG00000227232; ENSG00000278267; ENSG00000243485; ENSG00000284332; ENSG00000237613; ENSG00000268020; ENSG00000240361; ENSG00000186092; ENSG00000238009
5	gene_version	ENSEMBLgene	v99	The stable identifier version for the gene	5; 1; 2; 3; 6; 7; 4; 10; 12; 11
6	gene_symbol	ENSEMBLgene	v99	The official symbol of this gene	DDX11L1; WASH7P; MIR6859-1; MIR1302-2HG; MIR1302-2; FAM138A; OR4G4P; OR4G11P; OR4F5; AL627309.1
7	gene_source	ENSEMBLgene	v99	The annotation source for this gene	havana; mirbase; ensembl_havana; ensembl; havana_tagene; insdc
8	gene_biotype	ENSEMBLgene	v99	The biotype of this gene	transcribed_unprocessed_pseudogene; unprocessed_pseudogene; miRNA; lncRNA; protein_coding; processed_pseudogene; snRNA; transcribed_processed_pseudogene; misc_RNA; TEC
9	cytoband	CYTOBAND	2017-07-17	cytoband	1p36.33; 1p36.32; 1p36.31; 1p36.23; 1p36.22; 1p36.21; 1p36.13; 1p36.12; 1p36.11; 1p35.3
10	hgnc_id	HGNC	2017-06-05	A unique ID provided by the HGNC for each gene with an approved symbol.	37102; 38034; 50039; 52482; 35294; 32334; 14822; 31276; 14825; 48835
11	name	HGNC	2017-06-05	The full gene name approved by the HGNC.	DEAD/H-box helicase 11 like 1; WASP family homolog 7, pseudogene; microRNA 6859-1; MIR1302-2 host gene; microRNA 1302-2; family with sequence similarity 138 member A; olfactory receptor family 4 subfamily G member 4 pseudogene; olfactory receptor family 4 subfamily G member 11 pseudogene; olfactory receptor family 4 subfamily F member 5; capicua transcriptional repressor pseudogene 27
12	locus_group	HGNC	2017-06-05		pseudogene; non-coding RNA; protein-coding gene; other
13	locus_type	HGNC	2017-06-05	Specifies the genetic class of each gene entry.	pseudogene; RNA, micro; RNA, long non-coding; gene with protein product; readthrough; RNA, small nuclear; RNA, small nucleolar; unknown; immunoglobulin pseudogene; endogenous retrovirus
14	alias_symbol	HGNC	2017-06-05		FAM39F; hsa-mir-6859-1; hsa-mir-1302-2; F379; hsa-mir-6859-2; FLJ40008; FLJ22639; AL645608.1; MGC45873; DKFZP564C186|NET7|NET15|NIR|PPP1R112
15	alias_name	HGNC	2017-06-05		family with sequence similarity 39, member F; novel INHAT repressor|protein phosphatase 1, regulatory subunit 12; actinfilin; PGC-1- and ERR-induced regulator in muscle 1; calcium binding protein; beta-1,3-galactosyltransferase-6; adipolin|adipose-derived insulin-sensitizing factor; limitrin; cyclin S; matrix metalloproteinase 22|femalysin|matrix metalloproteinase in the female reproductive tract
16	prev_symbol	HGNC	2017-06-05	This field displays any symbols that were previously HGNC-approved nomenclature.	MIRN1302-2; NCRNA00115; C1orf170; G1P2; AGRIN; MIRN200B; MIRN200A; MIRN429; TTLL5; TXGP1L
17	prev_name	HGNC	2017-06-05		DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 like 1|DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 1; WAS protein family homolog 7, pseudogene; family with sequence similarity 138, member A; olfactory receptor, family 4, subfamily G, member 4 pseudogene; olfactory receptor, family 4, subfamily G, member 11 pseudogene; olfactory receptor, family 4, subfamily F, member 5; WW domain binding protein 1-like pseudogene 7; olfactory receptor, family 4, subfamily F, member 29; capicua homolog (Drosophila) pseudogene 7; mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 23
18	entrez_id	HGNC	2017-06-05		100287102; 653635; 102466751; 107985730; 100302278; 645520; 79504; 403263; 79501; 100420257
19	vega_id	HGNC	2017-06-05		OTTHUMG00000000961; OTTHUMG00000000958; OTTHUMG00000000959; OTTHUMG00000000960; OTTHUMG00000185779; OTTHUMG00000001095; OTTHUMG00000001094; OTTHUMG00000001257; OTTHUMG00000191963; OTTHUMG00000002854
20	ucsc_id	HGNC	2017-06-05		uc031tlb.1; uc001aak.4; uc001aal.1; uc010nxu.2; uc010nxv.2; uc031tlt.2; uc010nxx.3; uc001abt.5; uc001abw.2; uc001abz.5
21	ena	HGNC	2017-06-05		AM992871; AB065592; AI142379; AK097327; BC017762; BC047940; BC024295; AL050019; AY423763; AL136730
22	refseq_accession	HGNC	2017-06-05		NR_046018; NR_024540; NR_106918; XR_001737835; NR_036051; NR_026818; NG_004148; NG_004423; NM_001005484; NG_027060
23	ccds_id	HGNC	2017-06-05		CCDS30547; CCDS72675; CCDS41221; CCDS2; CCDS3; CCDS30550; CCDS4|CCDS53256; CCDS76083; CCDS5|CCDS44034; CCDS6
24	uniprot_ids	HGNC	2017-06-05		Q8NH21; Q6IEY1; Q96NU1; Q9Y3T9; Q6TDP4; Q494U1; Q5SV97; Q9HCC6; P05161; O00468
25	pubmed_id	HGNC	2017-06-05		19476624; 18159949; 11779631|15233989; 19123937; 14983052; 12477932; 29707762; 27734943; 20123734|22363708; 12063253
26	mgd_id	HGNC	2017-06-05		MGI:3031137; MGI:2446220; MGI:1931051; MGI:2678948; MGI:2387630; MGI:1921433; MGI:1855694; MGI:87961; MGI:3588193; MGI:2444364
27	rgd_id	HGNC	2017-06-05		RGD:1566059; RGD:1334011; RGD:1310271; RGD:1309387; RGD:708444; RGD:1311019; RGD:1304931; RGD:1310312; RGD:2067; RGD:1587009
28	lsdb	HGNC	2017-06-05		LRG_1231|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_1231.xml; Leiden Muscular Dystrophy pages|http://www.dmd.nl/nmdb2/home.php?select_db=AGRN|LRG_198|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_198.xml; LRG_1319|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_1319.xml; LRG_1261|http://ftp.ebi.ac.uk/pub/databases/lrgex/pending/LRG_1261.xml; dbPEX, PEX Gene Database|http://www.dbpex.org/home.php?select_db=PEX10; LRG_827|http://ftp.ebi.ac.uk/pub/databases/lrgex/pending/LRG_827.xml; LRG_1281|http://ftp.ebi.ac.uk/pub/databases/lrgex/pending/LRG_1281.xml; LRG_262|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_262.xml; Parkinson's disease Mutation Database|http://grenada.lumc.nl/LOVD2/TPI/home.php?select_db=PARK7; LRG_1165|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_1165.xml
29	cosmic	HGNC	2017-06-05		OR4F5; OR4F29; OR4F16; FAM87B; SAMD11; NOC2L; KLHL17; PLEKHN1; HES4; ISG15
30	omim_id	HGNC	2017-06-05		616765; 610770; 615921; 608060; 147571; 103320; 612091; 612090; 612094; 603905
31	mirbase	HGNC	2017-06-05		MI0022705; MI0006363; MI0026420; MI0000342; MI0000737; MI0001641; MI0022571; MI0022572; MI0022653; MI0015861
32	homeodb	HGNC	2017-06-05	a database of homeobox gene diversity	8485; 8497; 8528; 8458; 8409; 8416; 8573; 8563; 8487; 8460
33	snornabase	HGNC	2017-06-05		SR0000241; SR0000002; SR0000003; SR0000004; SR0000005; SR0000006; SR0000007; SR0000008; SR0000012; SR0000013
34	bioparadigms_slc	HGNC	2017-06-05		SLC35E2B; SLC35E2; SLC45A1; SLC2A7; SLC2A5; SLC25A33; SLC25A34; SLC30A2; SLC9A1; SLC2A1
35	orphanet	HGNC	2017-06-05	portal for rare diseases and orphan drugs	315470; 233062; 434205; 356939; 426034; 469968; 412653; 470030; 121991; 311140
36	pseudogene.org	HGNC	2017-06-05	database of identified pseudogenes	PGOHUM00000306540; PGOHUM00000296166; PGOHUM00000244554; PGOHUM00000295512; PGOHUM00000296173; PGOHUM00000243865; PGOHUM00000296175; PGOHUM00000296176; PGOHUM00000296177; PGOHUM00000296178
37	horde_id	HGNC	2017-06-05		OR4G4P; OR4G11P; OR4F5; OR4F29; OR4F16; OR11I1P; OR13Z1P; OR13Z2P; OR10T2; OR10K2
38	merops	HGNC	2017-06-05		M10.022; M13.008; C56.002; S01.229; S01.157; S01.155; S01.206; C14.010; A28.003; S01.933
39	imgt	HGNC	2017-06-05		IGKV1/OR1-1; CD1D; IGKV3/OR2-268; IGKC; IGKJ5; IGKJ4; IGKJ3; IGKJ2; IGKJ1; IGKV4-1
40	iuphar	HGNC	2017-06-05		ligandId:5319; objectId:1890; objectId:1873; objectId:740; objectId:658; objectId:1645; objectId:1964; objectId:2563; objectId:1963; objectId:1153
41	kznf_gene_catalog	HGNC	2017-06-05		2; 4; 5; 6; 1211; 8; 10; 13; 14; 15
42	mamit-trnadb	HGNC	2017-06-05		20; 8; 18; 16; 14; 19; 25; 7; 10; 12
43	cd	HGNC	2017-06-05		CD134; CD270; CD137; CD30; CD120b; CD240D; CD240CE; CD52; CD114; CD110
44	lncrnadb	HGNC	2017-06-05		snhg3; cyp4a22-as1; PDZK1IP1-AS1; LINC00568; linc00970; GAS5; KDM5BAS1; blacat1; linc00467; linc00538
45	enzyme_id	HGNC	2017-06-05		2.7.1.23; 2.7.11.1; 3.1.4.11; 1.11.1.20; 2.1.1.100; 4.2.1.11; 4.2.1.1; 1.1.1.47; 2.7.1.153; 2.7.7.1
46	lncipedia	HGNC	2017-06-05		FAM138A; LINC00115; FAM41C; LINC01342; TTLL10-AS1; LINC00982; TP73-AS1; LINC01134; LINC01346; LINC00337
47	chrom	dbNSFP	4.0c		1; 2; 3; 4; 5; 6; 7; X; 8; 9
48	Gene_old_names	dbNSFP	4.0c		.; MIRN1302-2; NCRNA00115; C1orf170; G1P2; AGRIN; MIRN200B; MIRN200A; MIRN429; TTLL5
49	Gene_other_names	dbNSFP	4.0c		.; FAM39F; hsa-mir-6859-1; hsa-mir-1302-2; F379; hsa-mir-6859-2; hsa-mir-6723; FLJ40008; FLJ22639; AL645608.1
50	Uniprot_acc(HGNC/Uniprot)	dbNSFP	4.0c		.; Q8NH21; Q6IEY1; Q96NU1; Q9Y3T9; Q6TDP4; Q494U1; Q5SV97; Q9HCC6; P05161
51	Uniprot_id(HGNC/Uniprot)	dbNSFP	4.0c		.; OR4F5_HUMAN; OR4F3_HUMAN; SAM11_HUMAN; NOC2L_HUMAN; KLH17_HUMAN; PKHN1_HUMAN; PERM1_HUMAN; HES4_HUMAN; ISG15_HUMAN
52	Entrez_gene_id	dbNSFP	4.0c		100287102; 653635; 102466751; 107985730; 100302278; 645520; 79504; 403263; 79501; 100420257
53	CCDS_id	dbNSFP	4.0c		.; CCDS30547; CCDS72675; CCDS41221; CCDS2; CCDS3; CCDS30550; CCDS4;CCDS53256; CCDS76083; CCDS5;CCDS44034
54	Refseq_id	dbNSFP	4.0c		NR_046018; NR_024540; NR_106918; XR_001737835; NR_036051; NR_026818; NG_004148; NG_004423; NM_001005484; NG_027060
55	ucsc_id	dbNSFP	4.0c		.; uc031tlb.1; uc001aak.4; uc001aal.1; uc010nxu.2; uc010nxv.2; uc031tlt.2; uc010nxx.3; uc001abt.5; uc001abw.2
56	MIM_id	dbNSFP	4.0c		.; 616765; 610770; 615921; 608060; 147571; 103320; 612091; 612090; 612094
57	OMIM_id	dbNSFP	4.0c		618355; .; 616765; 610770; 615921; 608060; 147571; 103320; 612091; 612090
58	Pathway(Uniprot)	dbNSFP	4.0c		.; PATHWAY: Glycan metabolism; chondroitin sulfate biosynthesis.; ; PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.; ; PATHWAY: Protein modification; protein ubiquitination.; ; PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-pantothenate: step 1/5.; ; PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D- glyceraldehyde 3-phosphate: step 4/5.; ; PATHWAY: Phospholipid metabolism; phosphatidylinositol phosphate biosynthesis.; ; PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from nicotinamide D-ribonucleotide: step 1/1.; ; PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q9ES00}.; ; PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D- ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage): step 3/3.; 
59	Pathway(BioCarta)_short	dbNSFP	4.0c		.; ox40Pathway; agrPathway;alkPathway;gsk3Pathway;pitx2Pathway;ps1Pathway;hesPathway;wntPathway; acrPathway; HivnefPathway; gsPathway;CSKPathway;sppaPathway;agpcrPathway;biopeptidesPathway;CCR3Pathway;gcrPathway;cxcr4Pathway;erkPathway;fMLPpathway;tubbyPathway;mPRPathway;raccPathway;edg1Pathway;myosinPathway;gpcrPathway;bArrestinPathway;Par1Pathway; ptdinsPathway; myosinPathway;Par1Pathway; atmPathway; DNAfragmentPathway;caspasePathway;fasPathway;setPathway;HivnefPathway;deathPathway;mitochondriaPathway;tnfr1Pathway
60	Pathway(BioCarta)_full	dbNSFP	4.0c		.; OX40 Signaling Pathway; Agrin in Postsynaptic Differentiation;ALK in cardiac myocytes;Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages;Multi-step Regulation of Transcription by Pitx2;Presenilin action in Notch and Wnt signaling;Segmentation Clock;WNT Signaling Pathway; Ahr Signal Transduction Pathway; HIV-I Nef: negative effector of Fas and TNF; Activation of cAMP-dependent protein kinase, PKA;Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor;Aspirin Blocks Signaling Pathway Involved in Platelet Activation;Attenuation of GPCR Signaling;Bioactive Peptide Induced Signaling Pathway;CCR3 signaling in Eosinophils;Corticosteroids and cardioprotection;CXCR4 Signaling Pathway;Erk1/Erk2 Mapk Signaling pathway;fMLP induced chemokine gene expression in HMC-1 cells;G-Protein Signaling Through Tubby Proteins;How Progesterone Initiates Oocyte Membrane;Ion Channels and Their Functional Role in Vascular Endothelium;Phospholipids as signalling intermediaries;PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Signaling Pathway from G-Protein Families;b-arrestins in GPCR Desensitization;Thrombin signaling and protease-activated receptors; Phosphoinositides and their downstream targets.; PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Thrombin signaling and protease-activated receptors; ATM Signaling Pathway; Apoptotic DNA fragmentation and tissue homeostasis;Caspase Cascade in Apoptosis;FAS signaling pathway ( CD95 );Granzyme A mediated Apoptosis Pathway;HIV-I Nef: negative effector of Fas and TNF;Induction of apoptosis through DR3 and DR4/5 Death Receptors ;Role of Mitochondria in Apoptotic Signaling;TNFR1 Signaling Pathway
61	Pathway(ConsensusPathDB)	dbNSFP	4.0c		.; Olfactory transduction - Homo sapiens (human);Olfactory receptor activity;Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;GPCR downstream signalling; Olfactory transduction - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;GPCR downstream signalling; Oxidative phosphorylation; Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Validated transcriptional targets of TAp63 isoforms;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53; EGFR1; Mitochondrial biogenesis; Human papillomavirus infection - Homo sapiens (human); RIG-I-like receptor signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);RIG-I-like Receptor Signaling;Type II interferon signaling (IFNG);DNA Repair;Cytokine Signaling in Immune system;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;Negative regulators of DDX58/IFIH1 signaling;Termination of translesion DNA synthesis;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass;Interferon alpha/beta signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling; ECM-receptor interaction - Homo sapiens (human);Primary Focal Segmental Glomerulosclerosis FSGS;Splicing factor NOVA regulated synaptic proteins;Developmental Biology;Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Heparan sulfate/heparin (HS-GAG) metabolism;Integrin cell surface interactions;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Extracellular matrix organization;Metabolism;Metabolism of vitamins and cofactors;Integrin;role of nicotinic acetylcholine receptors in the regulation of apoptosis;agrin in postsynaptic differentiation;NCAM signaling for neurite out-growth;Retinoid metabolism and transport;NCAM1 interactions;Non-integrin membrane-ECM interactions;G alpha (i) signalling events;Axon guidance;Visual phototransduction;ECM proteoglycans;GPCR downstream signalling;Wnt Canonical;Wnt Mammals
62	Pathway(KEGG)_id	dbNSFP	4.0c		.; hsa04740; hsa04512; hsa04060; hsa00532;hsa01030; hsa04120;hsa05020; hsa04742; hsa04310;hsa04330;hsa04916;hsa05210;hsa05217; hsa00760; hsa04020;hsa04070;hsa04720;hsa04740;hsa04910;hsa04912;hsa04916;hsa05040;hsa05214
63	Pathway(KEGG)_full	dbNSFP	4.0c		.; Olfactory transduction; ECM-receptor interaction; Cytokine-cytokine receptor interaction; Chondroitin sulfate biosynthesis;Glycan structures - biosynthesis 1; Ubiquitin mediated proteolysis;Parkinson's disease; Taste transduction; Wnt signaling pathway;Notch signaling pathway;Melanogenesis;Colorectal cancer;Basal cell carcinoma; Nicotinate and nicotinamide metabolism; Calcium signaling pathway;Phosphatidylinositol signaling system;Long-term potentiation;Olfactory transduction;Insulin signaling pathway;GnRH signaling pathway;Melanogenesis;Huntington's disease;Glioma
64	Function_description	dbNSFP	4.0c		.; FUNCTION: Odorant receptor. {ECO:0000305}.; ; FUNCTION: May play a role in photoreceptor development. {ECO:0000250}.; ; FUNCTION: Acts as an inhibitor of histone acetyltransferase activity; prevents acetylation of all core histones by the EP300/p300 histone acetyltransferase at p53/TP53-regulated target promoters in a histone deacetylases (HDAC)-independent manner. Acts as a transcription corepressor of p53/TP53- and TP63-mediated transactivation of the p21/CDKN1A promoter. Involved in the regulation of p53/TP53-dependent apoptosis. Associates together with TP63 isoform TA*-gamma to the p21/CDKN1A promoter. {ECO:0000269|PubMed:16322561, ECO:0000269|PubMed:20123734, ECO:0000269|PubMed:20959462}.; ; FUNCTION: Substrate-recognition component of some cullin-RING- based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(KLHL17) mediates the ubiquitination and subsequenct degradation of GLUR6. May play a role in the actin-based neuronal function (By similarity). {ECO:0000250}.; ; FUNCTION: Controls the stability of the leptin mRNA harboring an AU-rich element (ARE) in its 3' UTR, in cooperation with the RNA stabilizer ELAVL1 (PubMed:29180010). Decreases the stability of the leptin mRNA by antagonizing the function of ELAVL1 by inducing its atypical recruitment from the nucleus to the cytosol (By similarity). Binds to cardiolipin (CL), phosphatidic acid (PA), phosphatidylinositol 4-phosphate (PtdIns(4)P) and phosphatidylserine (PS) (PubMed:18191643). Promotes apoptosis by enhancing BAX-BAK hetro-oligomerization via interaction with BID in colon cancer cells (PubMed:29531808) (By similarity). {ECO:0000250|UniProtKB:Q8C886, ECO:0000269|PubMed:18191643, ECO:0000269|PubMed:29180010, ECO:0000269|PubMed:29531808}.; ; FUNCTION: Regulates the expression of selective PPARGC1A/B and ESRRA/B/G target genes with roles in glucose and lipid metabolism, energy transfer, contractile function, muscle mitochondrial biogenesis and oxidative capacity. Required for the efficient induction of MT-CO2, MT-CO3, COX4I1, TFB1M, TFB2M, POLRMT and SIRT3 by PPARGC1A. Positively regulates the PPARGC1A/ESRRG-induced expression of CKMT2, TNNI3 and SLC2A4 and negatively regulates the PPARGC1A/ESRRG-induced expression of PDK4. {ECO:0000250|UniProtKB:Q149B8}.; ; FUNCTION: Transcriptional repressor. Binds DNA on N-box motifs: 5'-CACNAG-3' (By similarity). {ECO:0000250}.; ; FUNCTION: Ubiquitin-like protein which plays a key role in the innate immune response to viral infection either via its conjugation to a target protein (ISGylation) or via its action as a free or unconjugated protein. ISGylation involves a cascade of enzymatic reactions involving E1, E2, and E3 enzymes which catalyze the conjugation of ISG15 to a lysine residue in the target protein. Its target proteins include IFIT1, MX1/MxA, PPM1B, UBE2L6, UBA7, CHMP5, CHMP2A, CHMP4B and CHMP6. Can also isgylate: EIF2AK2/PKR which results in its activation, DDX58/RIG-I which inhibits its function in antiviral signaling response, EIF4E2 which enhances its cap structure-binding activity and translation- inhibition activity, UBE2N and UBE2E1 which negatively regulates their activity, IRF3 which inhibits its ubiquitination and degradation and FLNB which prevents its ability to interact with the upstream activators of the JNK cascade therby inhibiting IFNA- induced JNK signaling. Exhibits antiviral activity towards both DNA and RNA viruses, including influenza A, HIV-1 and Ebola virus. Restricts HIV-1 and ebola virus via disruption of viral budding. Inhibits the ubiquitination of HIV-1 Gag and host TSG101 and disrupts their interaction, thereby preventing assembly and release of virions from infected cells. Inhibits Ebola virus budding mediated by the VP40 protein by disrupting ubiquitin ligase activity of NEDD4 and its ability to ubiquitinate VP40. ISGylates influenza A virus NS1 protein which causes a loss of function of the protein and the inhibition of virus replication. The secreted form of ISG15 can: induce natural killer cell proliferation, act as a chemotactic factor for neutrophils and act as a IFN-gamma-inducing cytokine playing an essential role in antimycobacterial immunity. {ECO:0000269|PubMed:1373138, ECO:0000269|PubMed:16009940, ECO:0000269|PubMed:16112642, ECO:0000269|PubMed:16428300, ECO:0000269|PubMed:16434471, ECO:0000269|PubMed:16872604, ECO:0000269|PubMed:18305167, ECO:0000269|PubMed:19270716, ECO:0000269|PubMed:19357168, ECO:0000269|PubMed:2005397, ECO:0000269|PubMed:20133869, ECO:0000269|PubMed:20308324, ECO:0000269|PubMed:20639253, ECO:0000269|PubMed:21543490, ECO:0000269|PubMed:22693631, ECO:0000269|PubMed:22859821, ECO:0000269|PubMed:23229543, ECO:0000269|PubMed:7526157, ECO:0000269|PubMed:8550581}.; ; FUNCTION: Isoform 1: heparan sulfate basal lamina glycoprotein that plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ) and directs key events in postsynaptic differentiation. Component of the AGRN-LRP4 receptor complex that induces the phosphorylation and activation of MUSK. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Calcium ions are required for maximal AChR clustering. AGRN function in neurons is highly regulated by alternative splicing, glycan binding and proteolytic processing. Modulates calcium ion homeostasis in neurons, specifically by inducing an increase in cytoplasmic calcium ions. Functions differentially in the central nervous system (CNS) by inhibiting the alpha(3)- subtype of Na+/K+-ATPase and evoking depolarization at CNS synapses. This secreted isoform forms a bridge, after release from motor neurons, to basal lamina through binding laminin via the NtA domain.; FUNCTION: Isoform 1, isoform 4 and isoform 5: neuron-specific (z+) isoforms that contain C-terminal insertions of 8-19 AA are potent activators of AChR clustering. Isoform 5, agrin (z+8), containing the 8-AA insert, forms a receptor complex in myotubules containing the neuronal AGRN, the muscle-specific kinase MUSK and LRP4, a member of the LDL receptor family. The splicing factors, NOVA1 and NOVA2, regulate AGRN splicing and production of the 'z' isoforms.; FUNCTION: Agrin N-terminal 110 kDa subunit: is involved in regulation of neurite outgrowth probably due to the presence of the glycosaminoglcan (GAG) side chains of heparan and chondroitin sulfate attached to the Ser/Thr- and Gly/Ser-rich regions. Also involved in modulation of growth factor signaling (By similarity). {ECO:0000250, ECO:0000269|PubMed:19631309, ECO:0000269|PubMed:21969364}.; 
65	Disease_description	dbNSFP	4.0c		.; DISEASE: Immunodeficiency 38, with basal ganglia calcification (IMD38) [MIM:616126]: A primary immunodeficiency predisposing individuals to severe clinical disease upon infection with weakly virulent mycobacteria, including Mycobacterium bovis Bacille Calmette-Guerin (BCG) vaccines. Patients are also susceptible to Salmonella and Mycobacterium tubercolosis infections. Affected individuals have intracranial calcification. {ECO:0000269|PubMed:22859821}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Myasthenic syndrome, congenital, 8 (CMS8) [MIM:615120]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness. CMS8 is an autosomal recessive disease characterized by prominent defects of both the pre- and postsynaptic regions. Affected individuals have onset of muscle weakness in early childhood; the severity of the weakness and muscles affected is variable. {ECO:0000269|PubMed:19631309, ECO:0000269|PubMed:22205389, ECO:0000269|PubMed:24951643}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Immunodeficiency 16 (IMD16) [MIM:615593]: An autosomal recessive primary immunodeficiency associated with classic Kaposi sarcoma of childhood and poor T-cell recall immune responses due to complete functional OX40 deficiency. {ECO:0000269|PubMed:23897980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]: A bone disease characterized by vertebral abnormalities and ligamentous laxity that result in spinal misalignment and progressive severe kyphoscoliosis, thoracic asymmetry, and respiratory compromise resulting in early death. Additional skeletal features include elbow deformities with radial head dislocation, dislocated hips, clubfeet, and tapered fingers with spatulate distal phalanges. Many affected children have an oval face, flat midface, prominent eyes with blue sclerae, and a long philtrum. Palatal abnormalities and congenital heart disease are also observed. {ECO:0000269|PubMed:23664117, ECO:0000269|PubMed:23664118}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Robinow syndrome, autosomal dominant 2 (DRS2) [MIM:616331]: A rare skeletal dysplasia syndrome characterized by dysmorphic features resembling a fetal face, mesomelic limb shortening, hypoplastic external genitalia in males, costovertebral segmentation defects, and renal anomalies. {ECO:0000269|PubMed:25817014, ECO:0000269|PubMed:25817016}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Harel-Yoon syndrome (HAYOS) [MIM:617183]: A syndrome characterized by global developmental delay, hypotonia, intellectual disability, and axonal neuropathy. Some patients have optic atrophy and hypertrophic cardiomyopathy. HAYOS inheritance can be autosomal dominant or autosomal recessive. {ECO:0000269|PubMed:27640307}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Spinocerebellar ataxia 21 (SCA21) [MIM:607454]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA21 is characterized by onset in the first decades of life of slowly progressive relatively mild cerebellar ataxia associated with slight extrapyramidal features predominant in older patients and cognitive impairment predominant in younger patients. {ECO:0000269|PubMed:25070513, ECO:0000269|PubMed:29053796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Mental retardation, autosomal dominant 42 (MRD42) [MIM:616973]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD42 patients manifest global developmental delay commonly accompanied by hypotonia, seizures of various types, ophthalmological manifestations, and poor growth. {ECO:0000269|PubMed:25485910, ECO:0000269|PubMed:27108799, ECO:0000269|PubMed:27668284, ECO:0000269|PubMed:28087732}. Note=The disease is caused by mutations affecting the gene represented in this entry.; ; DISEASE: Generalized epilepsy with febrile seizures plus 5 (GEFS+5) [MIM:613060]: A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity. {ECO:0000269|PubMed:15115768}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, idiopathic generalized 10 (EIG10) [MIM:613060]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Juvenile myoclonic epilepsy 7 (EJM7) [MIM:613060]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 
66	MIM_phenotype_id	dbNSFP	4.0c		.; 616126;; 615120;; 615593;; 271640;615349;; 616331;; 617183;; 607454;; 616973;; 613060;
67	MIM_disease	dbNSFP	4.0c		.; [MIM:616126]Immunodeficiency 38, with basal ganglia calcification;; [MIM:615120]Myasthenic syndrome, congenital, 8 [recessive?];; [MIM:615593]Immunodeficiency 16 [recessive?];; [MIM:271640]Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures;; [MIM:616331]Robinow syndrome, autosomal dominant 2 [dominant?];; [MIM:617183]Harel-Yoon syndrome [dominant?] [recessive?];; [MIM:607454]Spinocerebellar ataxia 21;; [MIM:616973]Mental retardation, autosomal dominant 42 [dominant?];; [MIM:613060]Generalized epilepsy with febrile seizures plus 5 [dominant?];[MIM:613060]Epilepsy, idiopathic generalized 10;[MIM:613060]Juvenile myoclonic epilepsy 7;
68	Orphanet_disorder_id	dbNSFP	4.0c		.; 319563; 98914;98913; 1872; 431149; 75496;93359; 3107; 963;2965;314777;314786;314790; 496790; 98773
69	Orphanet_disorder	dbNSFP	4.0c		.; Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency; Presynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes; Cone rod dystrophy; Combined immunodeficiency due to OX40 deficiency; Ehlers-Danlos syndrome, progeroid type;Spondyloepimetaphyseal dysplasia with joint laxity; Autosomal dominant Robinow syndrome; Acromegaly;Prolactinoma;Familial isolated pituitary adenoma;Silent pituitary adenoma;Null pituitary adenoma; Optic atrophy-peripheral neuropathy-developmental delay syndrome; Spinocerebellar ataxia type 21
70	Orphanet_association_type	dbNSFP	4.0c		.; Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) (loss of function) in; Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in; Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in; Major susceptibility factor in; Major susceptibility factor in;Role in the phenotype of;Candidate gene tested in; Role in the phenotype of;Disease-causing germline mutation(s) in; Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in
71	Trait_association(GWAS)	dbNSFP	4.0c		.; Subjective response to lithium treatment[26503763];; Morning vs. evening chronotype[26955885];; Pancreatic cancer[29422604];; Parkinson's disease[26227905];; Blood protein levels[29875488;30072576];; Large artery stroke[24262325];Lead levels[26025379];Height[21998595];; Inflammatory bowel disease[23128233];; Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];; Blood protein levels[30072576];
72	GO_biological_process	dbNSFP	4.0c		.; G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell; negative regulation of transcription by RNA polymerase II;negative regulation of B cell apoptotic process;apoptotic process;chromatin assembly;cellular response to UV;negative regulation of histone acetylation;ribosomal large subunit biogenesis;regulation of signal transduction by p53 class mediator;negative regulation of intrinsic apoptotic signaling pathway; brain development;protein ubiquitination;actin cytoskeleton organization; response to hypoxia;positive regulation of apoptotic process;3'-UTR-mediated mRNA destabilization; regulation of transcription, DNA-templated;response to muscle activity; negative regulation of transcription by RNA polymerase II;somitogenesis;Notch signaling pathway;cell differentiation;regulation of neurogenesis; viral process;modification-dependent protein catabolic process;translesion synthesis;positive regulation of bone mineralization;negative regulation of protein ubiquitination;ISG15-protein conjugation;negative regulation of type I interferon production;regulation of interferon-gamma production;response to type I interferon;defense response to bacterium;negative regulation of viral genome replication;positive regulation of erythrocyte differentiation;defense response to virus;type I interferon signaling pathway; retinoid metabolic process;glycosaminoglycan biosynthetic process;glycosaminoglycan catabolic process;cytoskeleton organization;signal transduction;G protein-coupled acetylcholine receptor signaling pathway;extracellular matrix organization;receptor clustering;positive regulation of GTPase activity;clustering of voltage-gated sodium channels;positive regulation of synaptic growth at neuromuscular junction;positive regulation of transcription by RNA polymerase II;synapse organization;positive regulation of filopodium assembly; protein polyglycylation
73	GO_cellular_component	dbNSFP	4.0c		.; plasma membrane;integral component of membrane; nucleus; nucleus;nucleoplasm;nucleolus;cytosol;Noc1p-Noc2p complex;Noc2p-Noc3p complex; extracellular space;postsynaptic density;actin cytoskeleton;cell junction;dendrite cytoplasm;neuronal cell body;postsynaptic membrane; mitochondrion;cytoskeleton;plasma membrane;mitochondrial membrane; nucleus;cytoplasm; extracellular region;nucleoplasm;cytosol; extracellular region;basement membrane;Golgi lumen;cytosol;plasma membrane;integral component of membrane;cell junction;lysosomal lumen;synapse;collagen-containing extracellular matrix;extracellular exosome; integral component of membrane
74	GO_molecular_function	dbNSFP	4.0c		.; G protein-coupled receptor activity;olfactory receptor activity; chromatin binding;transcription corepressor activity;RNA binding;protein binding;nucleosome binding;histone binding;repressing transcription factor binding; POZ domain binding;protein-containing complex scaffold activity;actin filament binding; phosphatidylserine binding;protein binding;phosphatidic acid binding;cardiolipin binding;phosphatidylinositol phosphate binding; RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;transcription factor binding;sequence-specific DNA binding;protein dimerization activity;sequence-specific double-stranded DNA binding; protein binding;protein tag; dystroglycan binding;structural constituent of cytoskeleton;extracellular matrix structural constituent;calcium ion binding;protein binding;sialic acid binding;chondroitin sulfate binding;laminin binding;heparan sulfate proteoglycan binding; metal ion binding; protein binding;ATP binding;protein-glycine ligase activity
75	Tissue_specificity(Uniprot)	dbNSFP	4.0c		.; Ubiquitous (PubMed:18191643). Epressed in several cancer cell lines of differing origin (PubMed:29531808). {ECO:0000269|PubMed:18191643, ECO:0000269|PubMed:29531808}.;; Muscle-specific expression is increased by endurance exercise. {ECO:0000269|PubMed:23836911}.;; Detected in lymphoid cells, striated and smooth muscle, several epithelia and neurons. Expressed in neutrophils, monocytes and lymphocytes. Enhanced expression seen in pancreatic adenocarcinoma, endometrial cancer, and bladder cancer, as compared to non-cancerous tissue. In bladder cancer, the increase in expression exhibits a striking positive correlation with more advanced stages of the disease. {ECO:0000269|PubMed:22859821, ECO:0000269|PubMed:7490683}.;; Expressed in basement membranes of lung and kidney. Muscle- and neuron-specific isoforms are found. Isoforms (y+) with the 4 AA insert and (z+8) isoforms with the 8 AA insert are all neuron-specific. Isoforms (z+11) are found in both neuronal and non-neuronal tissues. {ECO:0000269|PubMed:16487930, ECO:0000269|PubMed:20551380, ECO:0000269|PubMed:9652404}.;; Expressed in lymph node, peripheral blood leukocytes and weakly in spleen.;; Ubiquitous. Isoform 5 is expressed in pancreas. {ECO:0000269|PubMed:17442889}.;; Ubiquitous. {ECO:0000269|PubMed:11551958}.;; Predominantly expressed by adipose tissues. {ECO:0000269|PubMed:22275362}.;; Ubiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:23863933}.;
76	Expression(egenetics)	dbNSFP	4.0c		.; skeletal muscle;heart;; bone;testis;unclassifiable (Anatomical System);; developmental;cochlea;thymus;epididymis;skin;stomach;testis;lens;lymphoreticular;unclassifiable (Anatomical System);choroid;kidney;larynx;uterus;retina;pancreas;muscle;head and neck;mammary gland;islets of Langerhans;visual apparatus;cervix;fovea centralis;liver;endometrium;bone;germinal center;brain;blood;heart;lung;salivary gland;ovary;macula lutea;lymph node;oesophagus;colon;placenta;prostate;optic nerve;gum;; choroid;larynx;epididymis;colon;head and neck;stomach;prostate;testis;unclassifiable (Anatomical System);; fovea centralis;cartilage;endometrium;skin;stomach;bone;germinal center;testis;lens;unclassifiable (Anatomical System);cerebellum;lung;salivary gland;choroid;retina;macula lutea;colon;head and neck;hypopharynx;mammary gland;optic nerve;; endometrium;unclassifiable (Anatomical System);; endometrium;bone;lacrimal gland;testis;brain;unclassifiable (Anatomical System);heart;lung;kidney;colon;prostate;skeletal muscle;breast;islets of Langerhans;; kidney;lymph node;oesophagus;blood;unclassifiable (Anatomical System);; thymus;spinal ganglion;alveolus;ganglion;skin;stomach;testis;lens;unclassifiable (Anatomical System);choroid;kidney;uterus;whole body;retina;pancreas;muscle;urinary;mammary gland;trophoblast;islets of Langerhans;visual apparatus;cervix;fovea centralis;iris;spleen;liver;peripheral nerve;cartilage;endometrium;bone;germinal center;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;ovary;macula lutea;lymph node;oesophagus;colon;placenta;prostate;aorta;optic nerve;medulla oblongata;
77	Expression(GNF/Atlas)	dbNSFP	4.0c		.; ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;globus pallidus;; atrioventricular node;superior cervical ganglion;; superior cervical ganglion;trigeminal ganglion;; thyroid;liver;placenta;prostate;testis;; ciliary ganglion;testis - interstitial;dorsal root ganglion;superior cervical ganglion;testis;; pons;temporal lobe;superior cervical ganglion;trigeminal ganglion;medulla oblongata;; ciliary ganglion;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;; prefrontal cortex;skeletal muscle;; ciliary ganglion;dorsal root ganglion;adipose tissue;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;
78	Interactions(IntAct)	dbNSFP	4.0c		.; PLEKHF2[unassigned1304];ECM1[unassigned1304];KRTAP5-7[unassigned1304];KRT34[unassigned1304];TRAF2[unassigned1304];TSC1[unassigned1304];TRAF1[unassigned1304];JMJD7[unassigned1304];KRT31[unassigned1304];BPIFA1[unassigned1304];REL[unassigned1304];PLAGL2[unassigned1304];TRIB3[unassigned1304];PRR20D[unassigned1304];CCHCR1[unassigned1304];NFKBID[unassigned1304];ZMYND12[unassigned1304];RTL8C[unassigned1304];GLYR1[unassigned1304];; MAGED1[17353931];ILK[17353931];HNRNPU[26496610];FOXQ1[25609649];HIST1H3A[16322561];IFI16[25665578];ATXN7[21078624];MYC[17353931];E2F3[22157815];HIF1AN[26972000];PHLDA3[17353931];NOP56[26496610];FOXB1[25609649];JUN[25609649];BRF2[17353931];EED[26496610];H3F3A[16322561];RPS6[29568061];FOXL1[25609649];RRP1B[20926688];GIPC1[17353931];MNDA[25665578];LRIF1[16189514];HIST2H3D[16322561];PPIB[30021884];TP53[16322561];; POM121[unassigned1304];HGS[unassigned1304];PCDHB12[unassigned1304];; PRKAA2[unassigned1304];USP54[unassigned1304];PPP1R32[unassigned1304];CALCOCO2[unassigned1304];PXN[unassigned1304];AKAP8L[unassigned1304];PPM1J[unassigned1304];FHL5[unassigned1304];KRT83[unassigned1304];CYSRT1[unassigned1304];ATXN1[unassigned1304];TP53BP2[25416956;unassigned1304];KRTAP6-2[unassigned1304];LPXN[25416956;unassigned1304];HOXA1[unassigned1304];TRIM27[25416956];LZTS2[25416956];PPP1R16B[unassigned1304];WWOX[unassigned1304];ZRANB1[unassigned1304];ARID5A[unassigned1304];MTUS2[unassigned1304];TRAF1[25416956;unassigned1304];NOTCH2NLA[unassigned1304];KRT31[unassigned1304];KRTAP19-6[unassigned1304];SORBS3[unassigned1304];RFX6[25416956];ABI2[unassigned1304];TRIP6[unassigned1304];KRT36[unassigned1304];REL[25416956;unassigned1304];TAX1BP1[25416956;unassigned1304];ZNF438[unassigned1304];TCF4[25416956];SPERT[25416956;unassigned1304];NFKBID[unassigned1304];GLYR1[unassigned1304];; FAM210B[unassigned1304];GPR152[unassigned1304];SLC13A4[unassigned1304];SLC30A2[unassigned1304];AQP6[unassigned1304];SLC16A10[unassigned1304];PEX12[unassigned1304];TMEM80[unassigned1304];; EEF1B2[20195357];HSP90AB1[20195357];RGS3[20195357];CMSS1[20195357];KIF5C[20195357];LRRIQ1[20195357];LTN1[20195357];ATP13A4[20195357];COPG2[20195357];ZC3H13[20195357];; UBA7[16189514;25416956;unassigned1304;17597759];ATL3[26259872];RPN2[26259872];PRKDC[26259872];TECR[26259872];SLC1A5[26259872];MAGT1[26259872];USP18[16189514;25416956;unassigned1304;25307056];RTN4[26259872];FSTL4[26259872];SEC61A1[26259872];EBP[26259872];SMPD4[26259872];TMEM43[26259872];NARS2[26259872];ARL6IP5[26259872];FLNB[19270716];QSOX2[26259872];KCNN4[26259872];BCAP31[26259872];SACM1L[26259872];SURF4[26259872];DHCR24[26259872];NFKB1[25609649];SLC4A7[26259872];PPM1B[16872604];ELF3[17353931];REEP5[26259872];DAD1[26259872];NEDD4[18305167];OSTC[26259872];STT3B[26259872];DHCR7[26259872];CLPTM1L[26259872];SEC22B[26259872];ERGIC3[26259872];ERGIC1[26259872];; PDIA3[17170699];TEPSIN[unassigned1304];APP[10673326;28106549];GFI1B[16713569];BOLL[unassigned1304];NUDCD1[29021621];ATXN7[21078624];MAGED1[unassigned1304];PYHIN1[25665578];ATN1[16713569];DAG1[unassigned1793];CACNA1A[21078624];; TFRC[unassigned1304];TOMM6[unassigned1304];
79	Interactions(BioGRID)	dbNSFP	4.0c		.; TNIP2[27609421];UBC[23314748];; L3MBTL1[28514442];SAMD7[26186194;28514442];NCAPH2[28514442];TRIM25[29117863];PRR20E[28514442];SIRT6[28514442];HNRNPLL[28514442];ASB3[28514442];; HIST2H2AA3[16322561];APP[21832049];EDA[26186194];MPG[23537643];ATN1[16713569];KIAA0020[26344197];ILK[17353931];HNRNPU[26496610];CHD4[28977666];CHD3[28977666];AATF[26344197];FGF3[28514442];RRP8[28514442];FOXQ1[25609649];MECP2[28514442];FBL[26344197];RPS14[28514442];XPO1[26673895];FGF8[28514442];RPL18A[26344197;28514442];PTTG1[30033366];SNAPC1[30033366];DHX15[26344197];RRP12[26344197];CPNE2[28514442];HIF1AN[26972000];MAGEB10[28514442];RBM34[28514442];JAK1[24413661];DDX18[26344197];RBFOX1[16713569];WDR36[26344197];EED[24457600;26496610];ZBTB38[26186194];DDX56[26344197];DDX54[26344197];HIST2H2BA[16322561];SIRT7[22586326];DDX52[26344197];FOXL1[25609649];ILF2[26186194];GTPBP4[26344197];FTSJ3[26344197];EBNA1BP2[26344197];NSA2[26344197];HIST4H4[16322561];DKC1[26344197];GRWD1[26344197];MTF1[28416769];MRTO4[26344197];RPL27[26344197];PLEKHO1[28514442];LRIF1[16189514];ZNF512[28514442];TP53[20959462;16322561];OBSL1[24711643];GLYR1[26344197];CUL7[24711643];DDX24[26344197];MAGED1[17353931];SHMT2[22658674];NOP2[26344197];MAK16[28514442];PDGFB[28514442];RPF2[26344197];SDAD1[26344197];RNF4[29180619];AURKB[20959462];RNF2[24457600];NOL6[26344197];NXF1[22658674];IFI16[25693804];ATXN7[21078624];PES1[26344197;25825154];RRS1[26344197];ZNF746[25315684];RPL18[28514442];SCN3B[28514442];NTRK1[25921289];NOP56[26496610];FOXB1[25609649];NPM1[26186194;28514442];BRF2[17353931];NIFK[26344197];PYHIN1[28077445];DDX31[26344197];PPP1CA[10637318];MOV10[22658674];TBL3[26344197];CCDC8[24711643];HIST3H3[16322561];MDM2[24413661];CEBPZ[26344197];; CUL3[21145461];KLHL2[28514442];PDZK1[28514442];DCN[26186194;28514442];; RFX6[25416956];REL[25416956];TP53BP2[25416956];TAX1BP1[25416956];LPXN[25416956];TCF4[25416956];TRIM27[25416956];TRAF1[25416956];LZTS2[25416956];SPERT[25416956];; LMNA[24623722];; RGS3[20195357];SHMT2[22658674];LTN1[20195357];PCBD1[20211142];COPG2[20195357];PCBD2[20211142];; UBE2D3[17719635];IFIT5[16009940];HNRNPU[16009940];PLOD3[16009940];UBE2L6[16009940];ENO1[16884686;16009940;16815975];PLOD1[16009940];IFIT1[16009940];IFIT3[16009940];IFIT2[16009940];HERC5[16009940;16815975;24693865];RGS3[16884686];CFL1[16009940;16815975];PLS3[16009940];TRIM25[17222803];UBAP2L[16009940];CCNL1[16009940];PLS1[16009940];DDX17[16009940];ACOT8[16009940];IFNA14[26186194;28514442];CSNK2A1[16009940];ACTN1[16009940];TMOD3[16009940];ZNF281[16009940];DYRK1A[16009940];ARID5B[16009940];ACTN4[16009940];PGD[16009940];QTRTD1[16009940];ATXN2L[16009940];ACLY[16009940];CIRH1A[16009940];EEF1A2[16009940];ZNF318[22939629];RPL24[16009940];LAP3[16009940];SNRNP200[16009940];PFN1[16009940];EZR[16009940];SQSTM1[25429107];CFTR[26618866];IFNA10[28514442];VCP[16009940];UBA7[16189514;16884686;16009940;22693631;14976209;20975683;25416956];YTHDC1[16009940];MEPCE[16009940];TARS[16009940];IQGAP1[16009940];ZC3HAV1[16009940];AAAS[16009940];FUT4[16884686];HELZ2[16009940];ATP5B[16009940];ATXN2[16009940];LDHA[16009940];CALD1[16009940];RDH11[16009940];BAG3[23824909];PRDX1[16009940;16815975];STK38[16884686];G3BP1[16009940];PGK1[16009940];SFN[17222803];MAP4[16009940];ZC3H15[16009940];IFNA21[28514442];HSPA8[16009940;16815975];XRCC6[16009940];SMAD4[16009940];CBX4[16009940];HSPA4[16884686];XRCC5[16009940];TNK2[28514442];MSN[16009940];EIF2AK2[16009940];DSTN[16815975];EEF2[16009940];PRDX6[16815975];GNB2L1[16009940];IFNW1[28514442];CLK1[16009940];HNRNPL[16009940];HNRNPK[16009940];FUBP3[16009940];NACA[16009940];FASN[16009940];RPL27A[16009940];OGDH[16009940];EIF4G1[16009940];LGMN[16009940];TOP2A[16009940];IFNA5[26186194;28514442];GPI[16009940];IFNA4[28514442];HSP90AB1[16009940];WDR1[16009940];IFNA1[28514442];PPP1R10[16009940];CLTC[16009940];GDI2[16009940];IFNA2[26186194;28514442];DDX42[16009940];HSPB1[16815975];CHD1[16009940];ELAVL1[16009940];IFNA8[26186194;28514442];FARS2[16009940];PTBP1[16009940];ATIC[16009940];SIN3A[16009940];PHGDH[16009940];CLIC1[16009940];CCT3[16009940];CCT2[16009940];HSP90AA1[16009940];WARS[16009940];ANXA2[16009940];ANXA3[16009940];DDX58[16009940];ANXA5[16009940];MYOF[16009940];SEPT2[18305167];SERPINB5[16009940];DDB2[16009940];SENP1[16009940];WDR33[16009940];EEF1G[16009940];ACTA1[16009940];PPM1B[16884686];DEPDC7[16009940];PKM[16009940];ELF3[17353931];PALLD[16009940];MYH9[16009940];ALDOA[16009940];TKT[16009940];GAPDH[16815975];CHMP5[20164219;16009940];PAFAH1B1[16009940];PLEC[16009940];WIBG[16009940];SF3B4[16009940];TAGLN[16009940];NFIX[16009940];AHNAK[16009940];GSTP1[16009940];ATP5A1[16009940];USP18[16189514;25307056;25416956];PSMA7[16009940];HDAC6[25429107];HSPD1[16009940];DNAJB1[16009940];RBM15B[16009940];GANAB[16009940];UGP2[22939629];RBBP4[16009940];FAM120C[16009940];DNAJB4[16009940];LMAN2[16009940];LMNA[16009940];FLNA[16009940];FLNB[16009940];NUP43[16009940];ABCF2[16009940];RPS27A[16009940];GBP1[16009940];IFNL3[28514442];CCT4[16009940];SF3A2[16009940];YTHDF3[16009940];STAT1[16009940];USP21[21399617];TXNRD1[16009940];GSR[16009940];MX1[16009940];NEDD4[18287095];ERCC2[16884686];HNRNPA2B1[16009940];SERBP1[16009940];CTNNB1[20581239];EPPK1[16009940];VIM[16009940];TAF2[16009940];RAN[16009940];HSPA1A[16009940];; PDIA3[17170699];CRP[28514442];PYHIN1[28077445];ATN1[16713569];CACNA1A[21078624];TUBG1[23443559];SKI[25670202];MOV10[22658674];NXF1[22658674];GFI1B[16713569];OLFM3[28514442];ZFP41[26186194;28514442];CAMKV[28514442];OS9[28514442];ATXN7[21078624];UBC[28190767];DAG1[8205617];
80	Interactions(ConsensusPathDB)	dbNSFP	4.0c		.; RTL8C[0.004];PROP1[0.958];REL[0.960];KRT34[0.267];PLAGL2[0.958];ECM1[0.004];CCHCR1[0.963];KRT31[0.267];TRAF1[0.067];GLYR1[0.960];TRAF2[0.067];KRTAP5-7[0.262];SAMD7[0.004];L3MBTL1[0.962];HNRNPLL[0.959];NCAPH2[0.962];ASB3[0.004];SIRT6[0.961]; TP53[0.999];TP53[NA];AURKB[NA];TP63[0.999];EED[0.999];ATXN7[0.992];BRF2[0.999];PHLDA3[0.366];ATP1A1[NA];KRT1[NA];SUN2[NA];INTS5[NA];SEC61A1[NA];INTS3[NA];KDM1A[NA];AGPAT5[NA];HSPA5[NA];GPAM[NA];SHOC2[NA];KRT14[NA];ALB[NA];MSH6[NA];LMNA[NA];HELLS[NA];PARP1[NA];SCD[NA];IMPA1[NA];MYO1C[NA];PGAP1[NA];GTPBP2[NA];HNRNPU[NA];E2F3[NA];XRCC5[NA];SLC25A10[NA];DHX33[NA];EFTUD2[NA];NUP93[NA];RBSN[NA];INTS6[NA];PRKDC[NA];SLC2A1[NA];IMMT[NA];AKAP8[NA];POLG[NA];CTNNB1[NA];CTNNA1[NA];SMARCA1[NA];KRT9[NA];MYO1B[NA];ATP2A2[NA];L3MBTL3[NA];TRIM28[NA];MRPL57[NA];NDUFS1[NA];SLC25A5[NA];RAB13[NA];MSH2[NA];ITGB1[NA];NAT10[NA];NOLC1[NA];TRRAP[NA];AHCTF1[NA];SLC27A4[NA];SMPD4[NA];DDX41[NA];NUMA1[NA];WRN[NA];SFMBT1[NA];AFG3L2[NA];MYBBP1A[NA];SLC25A4[NA];ENOX2[NA];TFRC[NA];HSPA9[NA];KAT2A[NA];SP1[NA];SLC25A3[NA];RHOT1[NA];ZBED4[NA];GPD2[NA];LRPPRC[NA];LBR[NA];TCERG1[NA];ACADS[NA];NOTCH3[NA];ALPI[NA];SLC25A6[NA];TRIM23[NA];EEF1A1[NA];PMM1[NA];ATAD3A[NA];RPS27L[NA];DDB1[NA];CPT1A[NA];HADHA[NA];TMEM33[NA];CCDC9[NA];NCL[NA];MYO6[NA];CEBPZ[NA];NPLOC4[NA];TCF7L2[NA];DDX21[NA];ZNF148[NA];RB1[NA];TNXB[NA];HSPA6[NA];CLASP1[NA];HLTF[NA];MATR3[NA];TECR[NA];STT3A[NA];RPS3[NA];SLC16A3[NA];DOCK8[NA];RFC1[NA];NUP98[NA];NUP205[NA];DHX9[NA];DHCR7[NA];XRCC6[NA];RHOT2[NA];ZNF300[NA];PCLO[NA];ADGRF5[NA];NCAPG[NA];ZC3H11A[NA];SYMPK[NA];FOXL1[NA];YY1[NA];SIX5[NA];ORC3[NA];IARS[NA];INTS3[NA];STOM[NA];NOVA1[NA];RAD50[NA];NELFCD[NA];RANBP2[NA];ECPAS[NA];TOMM70[NA];SMARCA5[NA];MDN1[NA];DDX39A[NA];BTAF1[NA];SATB1[NA];RMDN3[NA];PI4KA[NA];YARS[NA];HELLS[NA];ARID3B[NA];RANGAP1[NA];UBE4A[NA];RALY[NA];GTF3C5[NA];TOMM40[NA];ADAR[NA];LMNB2[NA];ORC4[NA];DARS2[NA];SCRIB[NA];UTP6[NA];MRPS30[NA];SMC3[NA];GTF3C1[NA];NR2F1[NA];IRF9[NA];CHD1L[NA];PDS5A[NA];DCUN1D5[NA];CPSF2[NA];SMC4[NA];NR2C2[NA];KIF22[NA];NCAPD2[NA];CKAP5[NA];GBF1[NA];HK2[NA];DYNC1H1[NA];ZFHX4[NA];POLE[NA];SMARCA1[NA];NEMP1[NA];NCAPH[NA];SNX2[NA];NSF[NA];GTF3C4[NA];EEF1D[NA];ARID3A[NA];STAG1[NA];AARS2[NA];SMPD4[NA];SMC1A[NA];FASN[NA];SPIDR[NA];SATB2[NA];CENPB[NA];ORC2[NA];FEN1[NA];HEATR1[NA];EIF4G1[NA];NSDHL[NA];HSPA14[NA];HDAC2[NA];HDAC6[NA];PA2G4[NA];SMC2[NA];RIF1[NA];MRPL45[NA];BAZ1A[NA];UTP20[NA];ABCF3[NA];NR3C1[NA];NOL9[NA];TLE3[NA];SMARCAD1[NA];HK3[NA];NUP133[NA];RINT1[NA];COPA[NA];GADD45GIP1[NA];MAP2K3[NA];NUP98[NA];NUP205[NA];DHFR[NA];UFL1[NA];VARS[NA];MRPL38[NA];GAPVD1[NA];NCAPG[NA];COG5[NA];H3F3A[0.999];HIST2H3A[0.999];RANBP2[NA];SMARCA5[NA];DDX39A[NA];SATB1[NA];BTAF1[NA];SYMPK[NA];ORC3[NA];RBBP5[NA];IARS[NA];LRWD1[NA];ACSL4[NA];GTF3C5[NA];ZMYM3[NA];GTF3C1[NA];HELLS[NA];YARS[NA];MCM6[NA];GATAD2B[NA];SF3B2[NA];UBE4A[NA];RANGAP1[NA];PBX1[NA];SF3A1[NA];PUM1[NA];KIF22[NA];CHD4[NA];NUP85[NA];CUX1[NA];SF3A3[NA];CTBP2[NA];PDS5A[NA];SMC4[NA];KIF1BP[NA];ANAPC7[NA];POGZ[NA];SMC1A[NA];ASH2L[NA];SATB2[NA];ORC2[NA];ZNF326[NA];HEATR1[NA];SF3B1[NA];CDC27[NA];GTF3C3[NA];MYO1A[NA];ZFR[NA];SMARCA1[NA];GTF3C2[NA];POLE[NA];RCC1[NA];NSF[NA];NDUFV1[NA];ZMYM2[NA];CCAR2[NA];GTF3C4[NA];FUBP3[NA];FOXQ1[NA];SMC2[NA];ADNP[NA];NUP160[NA];NUP107[NA];NUP133[NA];HIC2[NA];COPA[NA];ZBTB33[NA];TLE3[NA];HNRNPUL2[NA];ZNF143[NA];VARS[NA];HOXD13[NA];TFCP2[NA];KIF5B[NA];NUP98[NA];NUP205[NA];HIST1H3A[0.999];CNOT1[NA];PHACTR4[NA];NOTCH2[NA];BLM[NA];CEP89[NA];KCTD15[NA];NFKBIA[NA];ZRANB2[NA];NCKAP5L[NA];HIF1A[NA];NKAPD1[NA];RAVER2[NA];QRICH1[NA];TMCO1[NA];ASB6[NA];IFRD2[NA];HBS1L[NA];MAP3K21[NA];PPP6R1[NA];TCF12[NA];CNN2[NA];RPL37[NA];SSR3[NA];ZGPAT[NA];EIF4E[NA];PSMC5[NA];HACE1[NA];PSMD10[NA];PLCH1[NA];ASB13[NA];PFKM[NA];RTFDC1[NA];HDAC3[NA];EIF4ENIF1[NA];CASKIN2[NA];RELA[NA];DNAJB6[NA];NDUFAF4[NA];ANKRD44[NA];MAEA[NA];LZTS2[NA];SYNE2[NA];RAVER1[NA];TNKS[NA];RPS24[NA];ATAD1[NA];PPM1G[NA];ELOC[NA];NCOA3[NA];KIDINS220[NA];ANKFY1[NA];BTF3[NA];ZCCHC14[NA];CDC20[NA];TRMT10C[NA];NFKB2[NA];EXD2[NA];RNASEL[NA];TNRC6B[NA];GMDS[NA];SEC61B[NA];GPATCH8[NA];MTCH1[NA];TANK[NA];KDM3B[NA];ANKRD28[NA];OSBPL1A[NA];LSM11[NA];MAP3K7[NA];CEP350[NA];RPL27[NA];RIPK4[NA];HDLBP[NA];ELOB[NA];HIF1AN[NA];TLN2[NA];COPG1[NA];PSMC2[NA];ANKHD1[NA];CCAR2[NA];CFAP44[NA];PPP6R3[NA];SIK3[NA];NT5DC2[NA];ANKRD27[NA];ATAD3A[NA];ANKEF1[NA];ZNF622[NA];RRP8[NA];ASB8[NA];MIB2[NA];MLF2[NA];WDR77[NA];PARP8[NA];PSMD14[NA];NOTCH3[NA];HECTD1[NA];ZCCHC3[NA];RPS15[NA];POLR2B[NA];ARNT[NA];ILK[NA];EHMT1[NA];UBAP2L[NA];TNKS2[NA];VAPA[NA];ANKRD52[NA];ZBTB33[NA];EDC3[NA];CNOT11[NA];NFKBIE[NA];ANKS6[NA];HAUS4[NA];MORC4[NA];FMR1[NA];PLA2G6[NA];ANKRD50[NA];PSMD13[NA];RPRD2[NA];ANKS1A[NA];POLR2L[NA];ANKRD17[NA];NAA10[NA];ZNF131[NA];NCAPH[NA];POLE[NA];GTF3C3[NA];TLE4[NA];ZFR[NA];HK2[NA];DYNC1H1[NA];HEATR1[NA];MRPL27[NA];SATB2[NA];SMC1A[NA];SMPD4[NA];AARS2[NA];EEF1D[NA];ARID3A[NA];SMC4[NA];CTBP2[NA];PDS5A[NA];UBR5[NA];NDUFV2[NA];E4F1[NA];SF3A3[NA];GBF1[NA];NCAPD2[NA];IQGAP2[NA];WAPL[NA];SACM1L[NA];CTNND1[NA];ZBTB40[NA];UBE4A[NA];RALY[NA];RANGAP1[NA];ARID3B[NA];YARS[NA];GTF3C1[NA];MRPS30[NA];SMC3[NA];SCRIB[NA];DARS2[NA];STAG2[NA];ADAR[NA];DARS[NA];HK3[NA];GTF3C5[NA];TOMM40[NA];NOVA1[NA];LRWD1[NA];NUP160[NA];MRPL45[NA];MRPL24[NA];MRPL20[NA];RIF1[NA];IARS[NA];PA2G4[NA];SMC2[NA];ANP32C[NA];SIX5[NA];SYMPK[NA];NSDHL[NA];YY1[NA];HUWE1[NA];SATB1[NA];BTAF1[NA];DDX39A[NA];PRPF31[NA];SMARCA5[NA];MRPL51[NA];ECPAS[NA];RANBP2[NA];FUBP3[NA];GTF3C4[NA];COPG1[NA];CCAR2[NA];RCC1[NA];GTF3C2[NA];CTNNB1[NA];SALL1[NA];ZFHX4[NA];SF3B1[NA];DUSP9[NA];EIF4G1[NA];NOVA2[NA];FOXB1[NA];SKP2[NA];HOXA10[NA];QARS[NA];DHFR[NA];UFL1[NA];NUP205[NA];LARS[NA];TP53[NA];MRPL3[NA];GAPVD1[NA];MRPL18[NA];COG5[NA];MRPL38[NA];HOXD13[NA];VARS[NA];MEN1[NA];HNRNPUL2[NA];KPNA1[NA];TLE3[NA];MRPL50[NA];LRP1[NA];ZBTB33[NA];TFAP2A[NA];GADD45GIP1[NA];COPA[NA];HIC2[NA];TLE1[NA];ILK[0.629];MAGED1[0.656];GIPC1[0.292];NOL10[NA];SPOUT1[NA];WDR3[NA];RPF2[NA];GAR1[NA];RRP1[NA];GPATCH4[NA];DDX47[NA];PWP1[NA];ATXN2L[NA];REXO4[NA];NVL[NA];RBM19[NA];RBM34[NA];DDX24[NA];POP1[NA];KRR1[NA];BYSL[NA];IGF2BP3[NA];RBM28[NA];CCDC86[NA];NOL11[NA];FAM120A[NA];DDX52[NA];UTP14A[NA];DDX27[NA];C7orf50[NA];UTP18[NA];H2AFX[NA];SDC1[NA];SURF6[NA];ISG20L2[NA];HP1BP3[NA];LARP1[NA];CAPRIN1[NA];MAK16[NA];NOP10[NA];RPF1[NA];STRBP[NA];UTP15[NA];NKRF[NA];SPATS2L[NA];CCDC137[NA];EXOSC2[NA];LARP4B[NA];NOP16[NA];EXOSC10[NA];PELP1[NA];PES1[NA];RRP15[NA];DDX54[NA];NSD2[NA];DHX30[NA];DHX33[NA];USP36[NA];DDX50[NA];NIFK[NA];H1FX[NA];GLYR1[NA];NOP56[NA];NOL8[NA];RPP30[NA];CENPV[NA];LARP4[NA];RRP12[NA];BRIX1[NA];WDR12[NA];NAT10[NA];PABPC1[NA];DDX31[NA];CTCF[NA];LENG8[NA];ATXN2[NA];TENT4B[NA];LARP7[NA];MYBBP1A[NA];URB1[NA];RRP1B[NA];AATF[NA];PABPC4[NA];YTHDC2[NA];DKC1[NA];NHP2[NA];PDCD11[NA];ZNF711[NA];GRWD1[NA];RRP8[NA];KNOP1[NA];DHX57[NA];NOC3L[NA];TEX10[NA];PAK1IP1[NA];DDX51[NA];MNDA[NA];LAS1L[NA];ZC3HAV1[NA];ZCCHC3[NA];NOP53[NA];NOL6[NA];EXOSC6[NA];FTSJ3[NA];RRP7A[NA];XRN2[NA];PPP1CB[NA];UTP20[NA];RRS1[NA];EIF3A[NA];NSA2[NA];RACK1[NA];KRI1[NA];BOP1[NA];EXOSC7[NA];GTPBP4[NA];NOL9[NA];NOP2[NA];PLS3[NA];HIST1H1E[NA];PPAN[NA];STAU2[NA];WDR36[NA];EXOSC3[NA];UPF1[NA];STAU1[NA];DDX18[NA];RIOX1[NA];IGF2BP1[NA];DDX21[NA];GNL3[NA];CEBPZ[NA];PPP1CC[NA];COPA[NA];DDX6[NA];NGDN[NA];NOP58[NA];PUM3[NA];RCN2[NA];DDX10[NA];TRMT1L[NA];RSL1D1[NA];MTREX[NA];EBNA1BP2[NA];PNP[NA];CASC3[NA];GNL2[NA];MRTO4[NA];BMS1[NA];MKI67[NA];TBL3[NA];LYAR[NA];MOV10[NA];WDR75[NA];FBL[NA];URB2[NA];MYC[0.999];RPL5[NA];USP36[NA];RPL7L1[NA];FBL[NA];MOV10[NA];TBL3[NA];LYAR[NA];ACACB[NA];MKI67[NA];BMS1[NA];MRTO4[NA];NMNAT1[NA];GNL2[NA];EBNA1BP2[NA];PRKRA[NA];RSL1D1[NA];DHX37[NA];RFC1[NA];TRMT1L[NA];NUP205[NA];REPIN1[NA];DDX10[NA];RPS13[NA];RPL10A[NA];PUM3[NA];NGDN[NA];RPL31[NA];RSBN1[NA];ELOA[NA];RPLP0[NA];PDCD11[NA];RPL13[NA];LLPH[NA];PWP2[NA];GZF1[NA];NOL12[NA];MRPL11[NA];TSR1[NA];AATF[NA];MRPS31[NA];MYBBP1A[NA];RRP1B[NA];MRPS15[NA];RPL36A[NA];NIP7[NA];CTCF[NA];NAT10[NA];BRIX1[NA];RPL26L1[NA];WDR12[NA];ECH1[NA];DDX55[NA];NOL8[NA];H1FX[NA];NOP56[NA];BOP1[NA];RPL19[NA];ARF4[NA];KRI1[NA];RPS14[NA];LACTB[NA];RPL17[NA];UTP20[NA];RRS1[NA];ZNF512[NA];FANCI[NA];RRBP1[NA];RPL39[NA];FTSJ3[NA];NOL6[NA];MRPL24[NA];NOP53[NA];ZC3HAV1[NA];RPLP2[NA];LAS1L[NA];DDX51[NA];PAK1IP1[NA];TEX10[NA];RPL7A[NA];NOC3L[NA];MRPS34[NA];KNOP1[NA];RRP8[NA];GRWD1[NA];ESF1[NA];RPS9[NA];RPS23[NA];NOL10[NA];POLRMT[NA];SDAD1[NA];RPL18A[NA];RFC4[NA];MAK16[NA];SRP72[NA];MRPS16[NA];SLC25A1[NA];HADHB[NA];UTP23[NA];RPL3[NA];EIF6[NA];RPL32[NA];CEBPZ[NA];GNL3[NA];RSL24D1[NA];DDX21[NA];RPL35A[NA];RPL18[NA];MPHOSPH10[NA];ZNF286A[NA];DDX18[NA];GRPEL1[NA];STAU1[NA];RIOX1[NA];MRPL47[NA];NOM1[NA];RPLP1[NA];RPS17[NA];WDR36[NA];MRPL28[NA];MRPS10[NA];PPAN[NA];SLC39A7[NA];RPL4[NA];RPL14[NA];RPS6[NA];RPL36[NA];PTCD3[NA];NCL[NA];MRPS25[NA];NOP14[NA];RPL12[NA];MRPS26[NA];NEPRO[NA];RPL7[NA];HP1BP3[NA];SURF6[NA];HAGH[NA];NOP2[NA];DDX56[NA];WDR18[NA];HADHA[NA];C7orf50[NA];NOL9[NA];RPL13A[NA];GTPBP4[NA];DDX27[NA];DAP3[NA];NIFK[NA];DDX50[NA];SRP68[NA];DHX33[NA];RCL1[NA];DIEXF[NA];NUP188[NA];DHX30[NA];DDX54[NA];RPL37A[NA];RPS8[NA];RRP15[NA];PES1[NA];PELP1[NA];NPM3[NA];WDR43[NA];MRPS22[NA];NOP16[NA];EXOSC10[NA];UTP3[NA];RPS3A[NA];RPS24[NA];MCCC1[NA];CCDC137[NA];MAP7D1[NA];RPL30[NA];NKRF[NA];RPL26[NA];IMP3[NA];IMP4[NA];NOC4L[NA];EMD[NA];DIMT1[NA];HEATR1[NA];RPS4X[NA];BCCIP[NA];RPL28[NA];URB1[NA];ATP2A2[NA];RPL8[NA];DDX31[NA];RRP12[NA];PARN[NA];AKAP8L[NA];GTF3C3[NA];RPP30[NA];GLYR1[NA];LIN28B[NA];NSUN2[NA];DDX52[NA];CCDC86[NA];PCID2[NA];MRPS5[NA];IGF2BP3[NA];RBM28[NA];POP1[NA];KRR1[NA];BYSL[NA];DDX24[NA];MRPS18B[NA];RPL6[NA];RFC3[NA];RBM34[NA];RPL11[NA];ZKSCAN8[NA];NVL[NA];RBM19[NA];REXO4[NA];PWP1[NA];RRP1[NA];ABT1[NA];GPATCH4[NA];RPF2[NA];LTV1[NA];MRPS27[NA];WDR3[NA];RPL29[NA];LRIF1[0.999];DHX57[NA];ERCC6[NA];RPL7A[NA];NOL6[NA];SOGA1[NA];LSG1[NA];RPS14[NA];RPS25[NA];RARS[NA];KRI1[NA];RTRAF[NA];EIF2S3[NA];JADE2[NA];GTPBP4[NA];NOP2[NA];PINX1[NA];RPL7[NA];RPS6[NA];PPAN[NA];RPS27[NA];WDR36[NA];DDX18[NA];RIOX1[NA];MRM1[NA];DDX21[NA];GNL3[NA];RPS15A[NA];CEBPZ[NA];RFC4[NA];RPLP0[NA];RPS3[NA];NOP58[NA];TOP2A[NA];C8orf33[NA];RPL10A[NA];DDX10[NA];CDC6[NA];MEPCE[NA];DHX37[NA];RFC1[NA];RSL1D1[NA];EBNA1BP2[NA];MAP3K1[NA];DHX9[NA];MRTO4[NA];MKI67[NA];TBL3[NA];LYAR[NA];MLLT6[NA];FBL[NA];URB2[NA];HSD17B10[NA];RPL5[NA];LEMD2[NA];H1FX[NA];GLYR1[NA];NOP56[NA];FAM111A[NA];DDX55[NA];CENPV[NA];RPL22[NA];RRP12[NA];BRIX1[NA];EXOSC9[NA];NAT10[NA];GTF3C4[NA];PRRC2A[NA];USP10[NA];NIP7[NA];RPL8[NA];DECR1[NA];RPL23A[NA];MYBBP1A[NA];CCDC124[NA];URB1[NA];TRMT10C[NA];TSR1[NA];WDR74[NA];RPS4X[NA];CIRBP[NA];RPS2[NA];EIF2B1[NA];WDR3[NA];RPL11[NA];RFC3[NA];RPL6[NA];POP1[NA];RBM28[NA];RPL23[NA];RFC5[NA];ABCF1[NA];RFC2[NA];RPS12[NA];RPL13A[NA];C7orf50[NA];UBTF[NA];LARP1[NA];ATAD5[NA];RPL12[NA];RPL36[NA];RPL4[NA];RPL32[NA];RPL3[NA];IBTK[NA];SAMD1[NA];EIF2B4[NA];NOP10[NA];CCDC137[NA];RPL30[NA];RPS24[NA];RPS3A[NA];PNMA3[NA];RPL24[NA];NOP16[NA];RIOX2[NA];DEK[NA];UTP4[NA];RRP15[NA];DDX54[NA];DHX30[NA];NMT1[NA];SRP68[NA];DHX33[NA];LAS1L[NA];ZCCHC3[NA];TEX10[NA];NOL6[NA];EXOSC6[NA];FTSJ3[NA];NOP53[NA];PNO1[NA];TRIP12[NA];NOC3L[NA];CACYBP[NA];KRI1[NA];RACK1[NA];NSA2[NA];S100A8[NA];HSPA4L[NA];G3BP1[NA];BOP1[NA];CTSD[NA];EIF3A[NA];RRS1[NA];UTP20[NA];DCAF13[NA];NOP14[NA];PPAN[NA];HIST1H1E[NA];GTPBP4[NA];SRRM2[NA];NOP2[NA];NARS[NA];DNAJC9[NA];COPA[NA];PELO[NA];ZMPSTE24[NA];DDX18[NA];UPF1[NA];ATXN10[NA];WDR36[NA];GNL3[NA];CEBPZ[NA];DDX21[NA];RCC2[NA];TRMT1L[NA];RCN2[NA];DDX10[NA];WDR46[NA];NGDN[NA];PUM3[NA];ACTR3[NA];NOP58[NA];PHIP[NA];MOV10[NA];WDR75[NA];MKI67[NA];BMS1[NA];LYAR[NA];TBL3[NA];KIF5B[NA];SNRNP70[NA];VARS[NA];PNP[NA];RSL1D1[NA];MTREX[NA];MAP1B[NA];EBNA1BP2[NA];MRTO4[NA];XRCC6[NA];UTP4[NA];PES1[NA];PELP1[NA];RRP15[NA];GNL2[NA];PABPC1[NA];CCAR2[NA];S100A9[NA];USP10[NA];RANBP1[NA];NAT10[NA];DNMT1[NA];SERBP1[NA];CENPV[NA];H1FX[NA];TBCB[NA];WDR12[NA];BRIX1[NA];RRP12[NA];FEN1[NA];PDIA4[NA];UCHL1[NA];PWP2[NA];HIST1H1C[NA];LLPH[NA];DKC1[NA];MAT2A[NA];PDCD11[NA];EIF3L[NA];MCM4[NA];MYBBP1A[NA];C1QBP[NA];SAFB[NA];SARS2[NA];BTF3[NA];PABPC4[NA];TSR1[NA];HELZ[NA];NVL[NA];RRP1[NA];PWP1[NA];RBM34[NA];IFI16[NA];NUFIP2[NA];NOL10[NA];EMG1[NA];RPF2[NA];NOL11[NA];MSH6[NA];ATIC[NA];UTP14A[NA];NSUN2[NA];ABCF1[NA];SMARCA5[NA];DDX24[NA];KRR1[NA];POP1[NA];RBM28[NA];SLTM[NA];USP7[NA];PEG10[NA];C7orf50[NA];DDX27[NA];HP1BP3[NA];H2AFX[NA];CAPRIN1[NA];MAK16[NA];UTP6[NA];NUDT5[NA];ADAR[NA];MPHOSPH10[NA];PPM1G[NA];LARP4B[NA];DNTTIP2[NA];FKBP4[NA];NKRF[NA];RNH1[NA];NIFK[NA];DDX50[NA];SAFB2[NA];CHD4[NA];HAT1[NA];EXOSC10[NA];NOP16[NA];WDR43[NA];XRCC5[NA];EIF3C[NA];DDX54[NA];RRP9[NA];ABCF1[NA];LCOR[NA];PHF19[NA];RPL9[NA];SUZ12[NA];TCEA1[NA];AEBP2[NA];DDX21[NA];EZH2[NA];TFAP2A[NA];NOP2[NA];GTPBP4[NA];JARID2[NA];DDX10[NA];EPOP[NA];RBBP7[NA];EED[NA];PHF1[NA];MTF2[NA];RBBP4[NA];RBFOX1[0.936];ATN1[0.949];PPP1CA[0.993];AURKB[0.999];SIRT7[0.999];HIST3H3[0.999];HIST2H2AA3[0.015];HIST1H4A[0.017];APP[0.328];MPG[0.999];MDM2[0.999];JAK1[0.805];CUL7[0.990];OBSL1[0.934];CCDC8[0.032];RNF2[0.999];NPM1[0.999];ZBTB38[0.940];ILF2[0.999];EDA[0.355];CEBPZ[0.986];DDX52[0.999];DDX54[0.999];NIFK[0.999];AATF[0.997];DDX18[0.999];DDX24[0.999];DDX31[0.999];DDX56[0.999];DHX15[0.999];DKC1[0.999];EBNA1BP2[0.999];FBL[0.999];FTSJ3[0.999];GLYR1[0.979];GRWD1[0.999];GTPBP4[0.999];PUM3[0.999];MRTO4[0.999];NOP2[0.999];NSA2[0.999];PES1[0.999];RPL18A[0.999];RPL27[0.998];RRP12[0.997];RRS1[0.999];TBL3[0.999];WDR36[0.034];NOL6[0.999];RPF2[0.999];SDAD1[0.999];NTRK1[0.716];IFI16[0.999];XPO1[0.999];HNRNPU[0.999];NOP56[0.999];FOXB1[0.999];FOXL1[0.999];FOXQ1[0.999];ZNF746[0.993];MAK16[0.999];RPL18[0.997];MAGEB10[0.005];FGF8[0.006];RPS14[0.999];PDGFB[0.885];FGF3[0.304];PLEKHO1[0.797];RRP8[0.999];RBM34[0.999];MECP2[0.991];SCN3B[0.323];ZNF512[0.944];CPNE2[0.005];MTF1[0.939]; ACTC1[0.977];CUL3[0.665];DCN[0.005];KLHL2[0.939];PDZK1[0.955]; TRAF1[0.005];TRIP6[0.024];KRT36[0.004];TAX1BP1[0.005];KRT83[0.005];WWOX[0.004];AKAP8L[0.004];USP54[0.004];PRKAA2[0.019];ATXN1[0.005];TCF4[0.004];KRTAP6-2[0.005];TP53BP2[0.004];PPP1R32[0.006];LPXN[0.006];LZTS2[0.005];RFX6[0.005];HOXA1[0.005];KRTAP19-6[0.005];MTUS2[0.004];ZRANB1[0.004];CALCOCO2[0.013];REL[0.005];ARID5A[0.005];SORBS3[0.005];CYSRT1[0.015];SPERT[0.005];KRT31[0.005];NCK2[0.014];TRIM27[0.005];ABI2[0.005];CCDC57[0.004];DEF6[0.004];PPM1J[0.004];GLYR1[0.004];PXN[0.012]; SLC30A2[0.004];SLC13A4[0.004];LMNA[0.004]; RGS3[0.967];ZC3H13[0.005];ATP13A4[0.005];HSP90AB1[0.967];CMSS1[0.004];COPG2[0.528];EEF1B2[0.079];LTN1[0.005];LRRIQ1[0.004];KIF5C[0.317];PCBD1[0.969];PCBD2[0.005]; UBA7[0.999];NEDD4[0.943];UBE2L6[0.999];PPM1B[0.979];FLNB[0.930];IRF3[0.993];PCNA[0.608];XRCC6[0.567];IRF9[0.985];EZR[0.192];CSNK2A1[0.533];SMAD4[0.527];PLOD1[0.984];HNRNPK[0.153];ANXA5[0.878];EIF2AK2[0.989];WDR33[0.986];AHNAK[0.098];ATXN2L[0.005];DDX17[0.411];SERPINB5[0.998];TXNRD1[0.644];TOP2A[0.174];EEF1G[0.822];DDB2[0.318];EEF1A2[0.215];TMOD3[0.113];PGD[0.847];CALD1[0.331];CREBBP[NA];IRF3[NA];VCP[0.966];PSMA7[0.584];RACK1[0.127];ACTN4[0.793];PPP1R10[0.033];UBAP2L[0.087];LMNA[0.164];ARID5B[0.032];STAT1[NA];STAT2[NA];IRF9[NA];EP300[0.723];IRF4[0.980];PLOD3[0.204];HNRNPU[0.178];MX1[0.993];IRF1[NA];IRF9[NA];IFIT3[0.005];PLS1[0.532];STAT1[0.967];RPL27A[0.922];UBE2N[0.969];PTBP1[0.047];PFN1[0.081];IRF8[0.992];IRF7[0.979];IFIT1[0.994];G3BP1[0.637];ENO1[0.892];TKT[0.657];DYRK1A[0.041];HSP90AB1[0.988];VIM[0.514];LAP3[0.186];CLIC1[0.040];RELA[0.984];CBX4[0.201];PAFAH1B1[0.219];NUP43[0.419];IRF1[0.987];RAN[0.595];CLTC[0.968];IQGAP1[0.415];FUBP3[0.108];UTP4[0.029];FLNA[0.954];ALDOA[0.999];EIF4G1[0.990];HNRNPL[0.106];PLEC[0.258];OGDH[0.402];FASN[0.759];IFIT5[0.004];ACLY[0.921];YTHDC1[0.036];SIN3A[0.071];HSPD1[0.961];ZNF281[0.038];CCT4[0.858];GSTP1[0.890];MYH9[0.232];STAT1[NA];STAT2[NA];MYNN[0.029];SNRNP200[0.046];LGMN[0.771];CCNL1[0.032];CLK1[0.114];FARS2[0.247];HSPA8[0.965];HSP90AA1[0.965];FAM120C[0.004];SF3B4[0.044];CHMP5[0.631];ACOT8[0.410];MSN[0.069];TARS[0.780];ANXA3[0.118];SERBP1[0.174];EEF2[0.968];ANXA2[0.983];ACTA1[0.692];ATIC[0.880];DNAJB1[0.117];RDH11[0.118];MED14[0.048];GPI[0.999];LDHA[0.876];SF3A2[0.056];SENP1[0.127];IRF2[0.953];PRDX1[0.369];CFL1[0.558];CCT3[0.650];DDX58[0.996];RPS27A[0.982];HSPA1A[0.940];LMAN2[0.315];MAP4[0.103];TAGLN[0.579];RPL24[0.960];PYM1[0.101];CCT2[0.985];ACTN1[0.758];CREBBP[0.707];WARS[0.740];ATXN2[0.346];TAF2[0.043];WDR1[0.995];ELAVL1[0.672];GDI2[0.887];PKM[0.938];STAT1[NA];IRF9[NA];ABCF2[0.170];ZC3H15[0.173];PHGDH[0.999];RBBP4[0.063];ATP5F1A[0.418];SPI1[0.353];EPPK1[0.099];GSR[0.738];AAAS[0.182];IRF1[NA];IRF2[NA];HNRNPA2B1[0.129];CHD1[0.106];MYOF[0.122];GANAB[0.506];DDX42[0.101];HERC5[0.997];USP18[0.992];RTN4[NA];MAGT1[NA];ELF3[0.250];HSPA1L[NA];HNRNPK[NA];PIP[NA];HIST1H2AA[NA];SFXN1[NA];HIST1H1B[NA];ALOX12B[NA];HSPD1[NA];CHD3[NA];RPS3[NA];FBL[NA];AZGP1[NA];NFKB1[NA];LRRIQ4[NA];TRIM72[NA];TUBA4A[NA];HSPA8[NA];ALDH5A1[NA];VARS[NA];GAPDH[NA];ACTBL2[NA];TUFM[NA];MSH2[NA];UQCRC2[NA];RPS18[NA];PSMC2[NA];RAN[NA];PRKDC[NA];DIRAS2[NA];ACTA2[NA];HSPA9[NA];TARDBP[NA];HIST1H1C[NA];APRT[NA];HK1[NA];MRPS31[NA];BLMH[NA];PRSS1[NA];RIF1[NA];HSP90AB1[NA];ALPI[NA];CDK1[NA];HNRNPH1[NA];SLC1A5[NA];NSDHL[NA];LRPPRC[NA];RPS14[NA];VIM[NA];HNRNPA2B1[NA];ACTB[NA];EEF1A1[NA];PRSS3[NA];PDHB[NA];TUBB4A[NA];TUBB4B[NA];A2ML1[NA];PARP1[NA];INA[NA];AIFM1[NA];C4orf19[NA];ATP5F1A[NA];SLC25A12[NA];LMNB1[NA];FRMD8[NA];ELAVL1[NA];PRPH[NA];MTHFD1[NA];HIST1H2BB[NA];KPNA2[NA];RUVBL2[NA];SLC25A13[NA];VTN[NA];EIF4A1[NA];SYNCRIP[NA];FKBP8[NA];RBMX[NA];PRDX1[NA];CDSN[NA];SSR1[NA];REL[NA];ANKRD24[NA];RPS16[NA];TUBB1[NA];DDX21[NA];IGF2BP1[NA];RPS15A[NA];TUBB2A[NA];CAT[NA];HSPA6[NA];RPS10P5[NA];NAV3[NA];CEP112[NA];HIST1H1A[NA];GGCT[NA];GNAS[NA];RPS3A[NA];TUBB3[NA];HIST1H2BC[NA];STXBP4[NA];OAT[NA];HSP90AB2P[NA];HOXC8[NA];HNRNPU[NA];CCT3[NA];ATP5F1B[NA];HPF1[NA];HIST1H4A[NA];PFKP[NA];RUVBL1[NA];HIST1H2AB[NA];MAP3K8[NA];TUBG1[NA];SEMG2[NA];ANXA2[NA];CKAP5[NA];SEMG1[NA];RELA[NA];COPB2[NA];HNRNPM[NA];IGKC[NA];HIST1H2BA[NA];BSG[NA];PSMC3[NA];TFAM[NA];SLC25A5[NA];PSMD2[NA];EEF1G[NA];TTF2[NA];SLC25A4[NA];RPS4X[NA];H1F0[NA];CFAP73[NA];DBT[NA];RPS10[NA];EEF1D[NA];TUBB[NA];JCHAIN[NA];NFKB2[NA];RPL11[NA];ETFA[NA];NPEPPS[NA];SBSN[NA];DDX17[NA];FARSA[NA];HSPA2[NA];SNRPB[NA];ATP1A1[NA];PKM[NA];PRDX2[NA];NSUN2[NA];IRS4[NA];TOMM22[NA];DDX39A[NA];TNIP2[NA];HSPA5[NA];TMEM43[NA];SLC1A5[NA];KCNN4[NA];ATL3[NA];DHCR7[NA];QSOX2[NA];TECR[NA];MAGT1[NA];STT3B[NA];RTN4[NA];DHCR24[NA];BCAP31[NA];SEC22B[NA];SMPD4[NA];OSTC[NA];FSTL4[NA];PRKDC[NA];ARL6IP5[NA];SEC61A1[NA];REEP5[NA];ERGIC3[NA];SLC4A7[NA];RPN2[NA];DAD1[NA];EBP[NA];SACM1L[NA];SURF4[NA];ERGIC1[NA];CLPTM1L[NA];NARS2[NA];PPM1B[NA];IFNB1[NA];PPM1B[NA];UBA7[NA];UBE2E2[NA];SEPT2[0.124];UBE2D3[0.984];RGS3[0.676];ERCC2[0.531];HSPA4[0.808];STK38[0.096];FUT4[0.075];ATP5F1B[0.422];YTHDF3[0.004];RBM15B[0.035];DNAJB4[0.111];MEPCE[0.006];GBP1[0.967];IFIT2[0.115];DEPDC7[0.004];PALLD[0.089];NFIX[0.033];PGK1[0.876];PLS3[0.547];HELZ2[0.033];QTRT2[0.295];XRCC5[0.583];ZC3HAV1[0.162];TRIM25[0.993];SFN[0.996];USP21[0.007];DSTN[0.208];GAPDH[0.661];HSPB1[0.459];PRDX6[0.988];CTNNB1[0.643];UGP2[0.730];ZNF318[0.111];BAG3[0.606];HDAC6[0.466];SQSTM1[0.972];IFNA14[0.999];IFNA2[0.999];IFNA5[0.999];IFNA8[0.999];IFNW1[0.999];IFNA1[0.999];IFNA21[0.999];TNK2[0.191];IFNA10[0.999];IFNA4[0.999];IFNL3[0.999]; NCAM1[0.998];DAG1[0.991];LRP4[NA];MUSK[NA];MUSK[NA];SRC[NA];RAPSN[NA];CHRNG[NA];CHRNB1[NA];CACNA1A[0.246];ATXN7[0.012];APP[0.993];PDIA3[0.010];PHIP[NA];COL18A1[NA];FOXC1[NA];ZNF646[NA];GPC4[NA];DAXX[NA];HTATSF1[NA];RCN2[NA];XRCC6[NA];MDC1[NA];RSL1D1[NA];MAP1B[NA];MKI67[NA];LIG3[NA];H1FX[NA];MCM2[NA];RBBP7[NA];UBN1[NA];CTCF[NA];CCAR2[NA];RAI1[NA];ZMYM2[NA];C5orf24[NA];NUMA1[NA];MCM4[NA];HIST1H1C[NA];UCHL1[NA];PHF14[NA];ZNF428[NA];ZNF711[NA];TEX10[NA];LAS1L[NA];NR2F2[NA];RREB1[NA];BAZ1A[NA];YWHAH[NA];SATB1[NA];MBD1[NA];DDB1[NA];SDC1[NA];SRRM2[NA];TFAP2A[NA];DCAF1[NA];MGA[NA];GTPBP4[NA];USP7[NA];HIST1H1E[NA];PARP1[NA];UBN2[NA];RFX1[NA];ZNF148[NA];H2AFY2[NA];BAZ2A[NA];NBN[NA];COPA[NA];DNAJC9[NA];YWHAG[NA];ZMYM4[NA];TWNK[NA];HIRA[NA];SENP3[NA];HIST1H4A[NA];ZNF384[NA];LAMB1[NA];PPM1G[NA];NR2C2[NA];HSPG2[NA];PELP1[NA];XRCC5[NA];SUPT5H[NA];SDC2[NA];CHD4[NA];SAFB2[NA];TMPO[NA];NCOA5[NA];RNH1[NA];DNAJC7[NA];SMARCA1[NA];TTF2[NA];ATRX[NA];SUPT16H[NA];PYHIN1[NA];TFAM[NA];CBX5[NA];PARP2[NA];BAZ1B[NA];SAFB[NA];C1QBP[NA];SATB2[NA];MECP2[NA];TBP[NA];HOXA13[NA];RSF1[NA];ATP6V1B2[NA];RAD50[NA];CABIN1[NA];U2AF1[NA];SMARCA5[NA];NSUN2[NA];LAMC1[NA];TCF20[NA];ATIC[NA];PGK1[NA];HMBOX1[NA];HUWE1[NA];ATN1[0.011];GFI1B[0.012];TUBG1[0.016];ZFP41[0.009];SKI[0.210];CAMKV[0.007];CRP[0.999];OS9[0.057];OLFM3[0.999];UBC[0.109]; LGALS8[0.004];ARMC6[0.004];GBP5[0.218]
81	P(HI)	dbNSFP	4.0c		.; 0.06092; 0.15855; 0.10109; 0.24042; 0.09980; 0.19904; 0.06703; 0.20655; 0.10000
82	HIPred_score	dbNSFP	4.0c		.; 0.186891868710518; 0.263579308986664; 0.51941329240799; 0.352169781923294; 0.146139457821846; 0.285495072603226; 0.460647642612457; 0.636561334133148; 0.412388771772385
83	HIPred	dbNSFP	4.0c		.; N; Y
84	GHIS	dbNSFP	4.0c		.; 0.526388187; 0.641794967; 0.546707473; 0.551744031; 0.480431284; 0.510442854; 0.573494831; 0.443129556; 0.530395714
85	P(rec)	dbNSFP	4.0c		.; 0.07159; 0.08067; 0.13894; 0.09909; 0.09620; 0.11867; 0.22633; 0.64499; 0.16362
86	Known_rec_info	dbNSFP	4.0c		.; recessive; lof-tolerant
87	RVIS_EVS	dbNSFP	4.0c		.; 0.04; -2.65; 0.9; -0.12; -0.22; -0.23; 3.27; -0.6; -0.41
88	RVIS_percentile_EVS	dbNSFP	4.0c		.; 56.27; 0.75; 89.33; 45.13; 37.33; 37.11; 99.4; 18.14; 26.23
89	LoF-FDR_ExAC	dbNSFP	4.0c		.; 0.9905209; 0.3568659; 0.6597935; 0.3751482; 0.1809803; 0.9993496; 0.8494748; 4.90286E-06; 0.4954952
90	RVIS_ExAC	dbNSFP	4.0c		.; 2.274410941; 0.231569638; -1.365209057; 1.879999506; 0.410434686; 0.70374788; -0.175667739; 1.24272779; 0.691137693
91	RVIS_percentile_ExAC	dbNSFP	4.0c		.; 98.9036805; 65.47195952; 4.843081742; 97.96397807; 74.54370219; 85.01897476; 38.31696886; 94.1569785; 84.63947955
92	ExAC_pLI	dbNSFP	4.0c		.; 0.176329298172162; 1.35381157129201e-10; 1.33038194561114e-19; 2.51676266070248e-07; 2.01974835522321e-08; 0.00014794288110518; 0.00984781293610986; 0.17335234048116; 0.0908776364218918
93	ExAC_pRec	dbNSFP	4.0c		.; 0.644086264144236; 0.18370000637236; 0.0025628417280481; 0.722913600252338; 0.659994782009553; 0.245981533859779; 0.600249312746062; 0.826647657926747; 0.765691410287669
94	ExAC_pNull	dbNSFP	4.0c		.; 0.179584437683602; 0.816299993492259; 0.997437158271952; 0.277086148071396; 0.340005197792964; 0.753870523259116; 0.389902874317828; 1.59209302093807e-09; 0.143430953290439
95	ExAC_nonTCGA_pLI	dbNSFP	4.0c		.; 0.550302420215064; 3.87526200981969e-10; 1.95434996883495e-19; 4.71815672240551e-06; 5.57433430125823e-08; 0.000129277219206069; 0.00889061739074356; 0.0403025247483816; 0.338519010089551
96	ExAC_nonTCGA_pRec	dbNSFP	4.0c		.; 0.39663970580189; 0.177866269557236; 0.00167039389288093; 0.850701626623057; 0.639081791583738; 0.229411510944876; 0.578754997482166; 0.95969745668599; 0.601909186208019
97	ExAC_nonTCGA_pNull	dbNSFP	4.0c		.; 0.0530578739830465; 0.822133730055238; 0.998329606107119; 0.149293655220221; 0.360918152672919; 0.770459211835918; 0.41235438512709; 1.85656278974184e-08; 0.05957180370243
98	ExAC_nonpsych_pLI	dbNSFP	4.0c		.; 0.179613130021276; 2.28931804207666e-08; 1.42787593106998e-16; 6.50733790988587e-07; 2.94867415806838e-07; 0.00890752979462469; 0.0584431202198305; 0.432276824423558; 0.0833297729176883
99	ExAC_nonpsych_pRec	dbNSFP	4.0c		.; 0.623408532464667; 0.42248722639092; 0.0104452108536494; 0.659119875314906; 0.727056610292468; 0.549074235627792; 0.687740607257902; 0.56772317046328; 0.736478134286935
100	ExAC_nonpsych_pNull	dbNSFP	4.0c		.; 0.196978337514057; 0.5775127507159; 0.98955478914635; 0.340879473951303; 0.272943094840116; 0.442018234577583; 0.253816272522267; 5.11316184674638e-09; 0.180192092795376
101	gnomAD_pLI	dbNSFP	4.0c		.; 3.0650e-02; 1.3168e-02; 2.5957e-07; 2.6426e-29; 1.1416e-16; 1.8027e-03; 2.5764e-02; 3.9557e-01; 1.0785e-01
102	gnomAD_pRec	dbNSFP	4.0c		.; 6.1116e-01; 6.7560e-01; 3.0148e-01; 4.9621e-05; 1.9831e-02; 7.3042e-01; 5.7614e-01; 4.8061e-01; 8.8620e-01
103	gnomAD_pNull	dbNSFP	4.0c		.; 3.5819e-01; 3.1123e-01; 6.9852e-01; 9.9995e-01; 9.8017e-01; 2.6777e-01; 3.9809e-01; 1.2383e-01; 5.9548e-03
104	ExAC_del.score	dbNSFP	4.0c		.; -1.30231557829469; -1.28066949641572; -1.85618066193215; -2.54252356721664; -0.854090636010466; -0.655956146050992; -0.195411282716471; -0.107338132620471; -0.411262678743063
105	ExAC_dup.score	dbNSFP	4.0c		.; -2.53125239294469; -2.25597869426552; -1.63096181793128; -1.66066626021856; -0.871382761831082; -1.547525137109; -0.879111583779016; -1.38938551075959; -0.394193176188832
106	ExAC_cnv.score	dbNSFP	4.0c		.; -2.47162789907313; -2.31189826471188; -2.3252444322095; -1.53319165737073; -1.45000690532075; -0.676226119735614; -1.22537295612016; -0.823164297355822; -1.07852675058797
107	ExAC_cnv_flag	dbNSFP	4.0c		.; N; Y
108	GDI	dbNSFP	4.0c		.; 113.16669; 835.24604; 783.46189; 60.97395; 709.4528; 1800.58057; 1374.86701; 1338.6014; 350.3187
109	GDI-Phred	dbNSFP	4.0c		.; 2.31572; 5.65821; 5.53337; 1.58809; 5.29021; 7.82660; 6.95277; 6.86990; 3.96842
110	Gene damage prediction (all disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
111	Gene damage prediction (all Mendelian disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
112	Gene damage prediction (Mendelian AD disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
113	Gene damage prediction (Mendelian AR disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
114	Gene damage prediction (all PID disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
115	Gene damage prediction (PID AD disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
116	Gene damage prediction (PID AR disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
117	Gene damage prediction (all cancer disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
118	Gene damage prediction (cancer recessive disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
119	Gene damage prediction (cancer dominant disease-causing genes)	dbNSFP	4.0c		.; Medium; High; Low
120	LoFtool_score	dbNSFP	4.0c		.; 8.87E-01; 3.86E-01; 9.26E-01; 5.01E-01; 4.21E-01; 2.93E-01; 9.50E-01; 5.85E-01; 3.04E-01
121	SORVA_LOF_MAF0.005_HetOrHom	dbNSFP	4.0c		0.0; 3.9936102236421724E-4; 0.0023961661341853034; 0.001597444089456869; 0.0011980830670926517; 0.00439297124600639; 7.987220447284345E-4; 0.003993610223642172; 0.006789137380191693; 0.009584664536741214
122	SORVA_LOF_MAF0.005_HomOrCompoundHet	dbNSFP	4.0c		0.0; 7.987220447284345E-4; 3.9936102236421724E-4; 0.001996805111821086; 0.0011980830670926517; 0.0023961661341853034; 0.006389776357827476; 0.001597444089456869; 0.003194888178913738; 0.008386581469648562
123	SORVA_LOF_MAF0.001_HetOrHom	dbNSFP	4.0c		0.0; 3.9936102236421724E-4; 0.0023961661341853034; 0.001597444089456869; 0.0011980830670926517; 7.987220447284345E-4; 0.003993610223642172; 0.005191693290734824; 0.001996805111821086; 0.003194888178913738
124	SORVA_LOF_MAF0.001_HomOrCompoundHet	dbNSFP	4.0c		0.0; 3.9936102236421724E-4; 0.001996805111821086; 0.0011980830670926517; 0.0027955271565495207; 7.987220447284345E-4; 0.001597444089456869
125	SORVA_LOForMissense_MAF0.005_HetOrHom	dbNSFP	4.0c		0.0; 0.022763578274760384; 0.0762779552715655; 0.06589456869009584; 0.024361022364217253; 0.05151757188498403; 0.03274760383386582; 0.00718849840255591; 0.16853035143769968; 0.034345047923322686
126	SORVA_LOForMissense_MAF0.005_HomOrCompoundHet	dbNSFP	4.0c		0.0; 0.00439297124600639; 0.0059904153354632585; 0.008386581469648562; 7.987220447284345E-4; 0.005191693290734824; 0.001996805111821086; 0.003194888178913738; 0.017971246006389777; 0.001597444089456869
127	SORVA_LOForMissense_MAF0.001_HetOrHom	dbNSFP	4.0c		0.0; 0.008386581469648562; 0.036741214057507986; 0.04153354632587859; 0.019169329073482427; 0.03634185303514377; 0.03154952076677316; 0.010782747603833865; 0.00718849840255591; 0.07707667731629393
128	SORVA_LOForMissense_MAF0.001_HomOrCompoundHet	dbNSFP	4.0c		0.0; 0.001996805111821086; 0.001597444089456869; 3.9936102236421724E-4; 7.987220447284345E-4; 0.0023961661341853034; 0.00439297124600639; 0.003594249201277955; 0.0011980830670926517; 0.004792332268370607
129	Essential_gene	dbNSFP	4.0c		.; N; E
130	Essential_gene_CRISPR	dbNSFP	4.0c		.; N; E
131	Essential_gene_CRISPR2	dbNSFP	4.0c		.; N; E; S
132	Essential_gene_gene-trap	dbNSFP	4.0c		.; N; H; E; K
133	Gene_indispensability_score	dbNSFP	4.0c		.; 0.114371359811310; 0.000683535100850493; 0.187549044243291; 0.946496023965855; 0.323193869751981; 0.259498654175253; 0.99544852671045; 0.893955099408202; 0.88298741376669
134	Gene_indispensability_pred	dbNSFP	4.0c		.; N; E
135	MGI_mouse_gene	dbNSFP	4.0c		.; Olfr1303; Samd11; Noc2l; Klhl17; Plekhn1; Perm1; Isg15; Agrn; Rnf223
136	MGI_mouse_phenotype	dbNSFP	4.0c		.; endocrine/exocrine gland phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; ; skeleton phenotype; ; growth/size/body region phenotype; homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); ; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; ; homeostasis/metabolism phenotype; ; hematopoietic system phenotype; cellular phenotype; immune system phenotype; ; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; liver/biliary system phenotype; ; growth/size/body region phenotype; ; taste/olfaction phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 
137	ZFIN_zebrafish_gene	dbNSFP	4.0c		.; noc2l; agrn; sdf4; ints11; mmp23bb; gnb1a; prkcz; skia; rer1
138	ZFIN_zebrafish_structure	dbNSFP	4.0c		.; anatomical system; CaP motoneuron; dorsal longitudinal anastomotic vessel; hemopoiesis; liver; neuromast; bulbus arteriosus; retinal rod cell; trunk
139	ZFIN_zebrafish_phenotype_quality	dbNSFP	4.0c		.; quality; decreased length; aplastic; disrupted; decreased size; decreased amount; amorphous; bent; process quality
140	ZFIN_zebrafish_phenotype_tag	dbNSFP	4.0c		.; abnormal; ameliorated; exacerbated
141	Adipose - Subcutaneous	GTEx	v8		0; 4.06403; 0.0406478; 0.0453961; 0.018421; 0.0193245; 3.24159; 5.13759; 0.151021; 7.48193
142	Adipose - Visceral (Omentum)	GTEx	v8		0; 3.37111; 0.0407008; 0.0446407; 0.0214816; 0.0376293; 5.15433; 7.79802; 0.134715; 0.0597251
143	Adrenal Gland	GTEx	v8		0; 2.68549; 0.0363952; 0.0543848; 0.057972; 0.0161567; 0.0153541; 3.66854; 6.50306; 0.104671
144	Artery - Aorta	GTEx	v8		0; 4.04762; 0.0292094; 0.0243222; 3.64269; 6.23226; 0.140667; 7.26795; 0.24707; 0.142936
145	Artery - Coronary	GTEx	v8		0; 3.90076; 0.0412303; 0.00796076; 0.0210623; 3.6018; 5.24138; 0.125424; 0.0762306; 6.67937
146	Artery - Tibial	GTEx	v8		0; 3.63963; 0.0393011; 0.0444898; 0.0116735; 1.46107; 2.57004; 0.128387; 6.76498; 0.205976
147	Bladder	GTEx	v8		0; 5.16375; 0.0354698; 0.043814; 0.0146345; 0.0161237; 3.5028; 5.45536; 0.202102; 0.0715399
148	Brain - Amygdala	GTEx	v8		0; 1.43859; 0.0496721; 0.0638307; 0.0788694; 0.0190451; 0.0146865; 1.40081; 1.22339; 0.0424387
149	Brain - Anterior cingulate cortex (BA24)	GTEx	v8		0; 1.69285; 0.0535347; 0.0679508; 0.0767212; 0.0207742; 0.017505; 1.3302; 1.031; 0.0554014
150	Brain - Caudate (basal ganglia)	GTEx	v8		0; 1.56605; 0.0242641; 0.0455724; 0.0720353; 0.0826726; 0.0185414; 0.0177871; 1.03828; 1.24869
151	Brain - Cerebellar Hemisphere	GTEx	v8		0; 4.99231; 0.0246426; 0.0468637; 0.0598598; 0.0222933; 0.0294434; 1.82934; 2.75202; 0.108197
152	Brain - Cerebellum	GTEx	v8		0; 5.72099; 0.0372239; 0.0499559; 0.057719; 0.0229453; 0.035823; 2.19213; 3.58486; 0.144657
153	Brain - Cortex	GTEx	v8		0; 2.48317; 0.027366; 0.0429845; 0.070455; 0.0843648; 0.0239836; 0.0198806; 2.4306; 2.52752
154	Brain - Frontal Cortex (BA9)	GTEx	v8		0; 2.14667; 0.0303822; 0.0421429; 0.0731617; 0.0740079; 0.0252608; 0.018736; 1.84819; 1.93137
155	Brain - Hippocampus	GTEx	v8		0; 1.68599; 0.0529141; 0.0775019; 0.103119; 0.0200628; 0.0137078; 1.38786; 1.28238; 0.0491965
156	Brain - Hypothalamus	GTEx	v8		0; 1.74811; 0.0247143; 0.039666; 0.0639793; 0.0831419; 0.0192925; 0.0239156; 1.81518; 1.85153
157	Brain - Nucleus accumbens (basal ganglia)	GTEx	v8		0; 1.53899; 0.0306685; 0.0445129; 0.0592968; 0.0814785; 0.020002; 0.0219216; 1.0647; 1.16742
158	Brain - Putamen (basal ganglia)	GTEx	v8		0; 1.44167; 0.0234739; 0.0484946; 0.064973; 0.0984991; 0.0164584; 0.0152729; 0.913428; 0.875966
159	Brain - Spinal cord (cervical c-1)	GTEx	v8		0; 2.73049; 0.0416046; 0.0571243; 0.0707495; 0.017476; 0.0243637; 2.55968; 2.4745; 0.0696774
160	Brain - Substantia nigra	GTEx	v8		0; 1.74194; 0.0195261; 0.0466989; 0.0664603; 0.0731943; 0.0191066; 0.0156567; 1.82961; 1.56403
161	Breast - Mammary Tissue	GTEx	v8		0; 4.43876; 0.0300396; 0.038886; 0.0455919; 0.0230619; 0.0279442; 3.99419; 6.48057; 0.164492
162	Cells - Cultured fibroblasts	GTEx	v8		0; 1.6786; 0.0965916; 0.190796; 0.0661497; 0.0613942; 3.57225; 0.217631; 0.152828; 0.116066
163	Cells - EBV-transformed lymphocytes	GTEx	v8		0; 2.49477; 0.0309826; 0.00861359; 0.0174349; 1.33712; 2.77364; 0.0739324; 4.6837; 0.109943
164	Cervix - Ectocervix	GTEx	v8		0; 5.62935; 0.0505553; 0.041129; 0.054907; 4.22459; 5.96316; 0.182182; 9.15458; 0.261122
165	Cervix - Endocervix	GTEx	v8		0; 7.09749; 0.0240885; 0.0244735; 0.0701969; 9.43772; 10.957; 0.0783685; 0.26236; 0.288031
166	Colon - Sigmoid	GTEx	v8		0; 4.64777; 0.0154943; 0.0433274; 0.0445988; 0.016118; 0.0134647; 2.14222; 3.46202; 0.141945
167	Colon - Transverse	GTEx	v8		0; 3.59509; 0.032754; 0.045452; 0.0500047; 0.0158663; 0.0182629; 2.4653; 4.55942; 0.0859828
168	Esophagus - Gastroesophageal Junction	GTEx	v8		0; 4.32641; 0.0356929; 0.0410858; 0.0477532; 0.0178668; 0.0221668; 3.19478; 5.50862; 0.146489
169	Esophagus - Mucosa	GTEx	v8		0; 3.11749; 0.0226201; 0.0376992; 0.023875; 0.115794; 15.9219; 26.6087; 0.713387; 0.21749
170	Esophagus - Muscularis	GTEx	v8		0; 4.10335; 0.0428965; 0.0488647; 0.0162133; 0.0183116; 3.08; 5.31485; 0.128642; 0.0825191
171	Fallopian Tube	GTEx	v8		0; 6.13409; 0.0360075; 0.0349997; 8.34542; 15.9994; 0.198979; 0.22145; 8.64935; 0.439877
172	Heart - Atrial Appendage	GTEx	v8		0; 1.52031; 0.0364598; 0.060374; 0.0831301; 0.0157693; 0.0143291; 1.65893; 2.9368; 0.0770381
173	Heart - Left Ventricle	GTEx	v8		0; 0.924962; 0.0178934; 0.0511975; 0.0725549; 0.0976225; 0.0162799; 0.0105452; 0.813732; 1.34022
174	Kidney - Cortex	GTEx	v8		0; 2.77081; 0.0176647; 0.0389038; 0.0580308; 0.076292; 0.0170238; 0.0191362; 4.16909; 4.68101
175	Kidney - Medulla	GTEx	v8		0; 2.21451; 0.0258349; 0.0879419; 8.31617; 11.4854; 0.0865316; 0.0875101; 8.96186; 0.180101
176	Liver	GTEx	v8		0; 1.76541; 0.0332748; 0.0433574; 0.060538; 0.0168633; 0.0228274; 3.17038; 4.60361; 0.0443455
177	Lung	GTEx	v8		0; 4.50841; 0.0392844; 0.0429601; 0.0353962; 0.131979; 19.1697; 33.4047; 1.15815; 0.26062
178	Minor Salivary Gland	GTEx	v8		0; 3.52767; 0.0330092; 0.0322058; 0.019963; 0.0464406; 6.63199; 13.1984; 0.182025; 0.194032
179	Muscle - Skeletal	GTEx	v8		0; 1.41667; 0.0375151; 0.0542007; 0.063905; 0.013651; 0.00540119; 0.309132; 0.585619; 0.0464001
180	Nerve - Tibial	GTEx	v8		0; 6.68531; 0.0391109; 0.0193682; 0.0155048; 2.04993; 3.14203; 0.216806; 0.109404; 12.8797
181	Ovary	GTEx	v8		0; 6.6341; 0.0295117; 0.0987076; 9.52798; 19.0433; 0.423316; 0.278667; 0.056335; 12.9414
182	Pancreas	GTEx	v8		0; 1.80871; 0.0247443; 0.0149573; 0.0286642; 3.32115; 6.37238; 0.092735; 3.07287; 0.185257
183	Pituitary	GTEx	v8		0; 5.42546; 0.0287434; 0.036633; 0.0249412; 0.0851536; 9.20608; 14.5037; 0.189712; 0.180994
184	Prostate	GTEx	v8		0; 7.08318; 0.0205405; 0.0423377; 0.0430292; 0.0285258; 0.0635053; 12.8403; 19.0873; 0.399476
185	Skin - Not Sun Exposed (Suprapubic)	GTEx	v8		0; 5.93298; 0.0267156; 0.0430173; 0.0488484; 0.0189649; 0.0263983; 5.85551; 9.92311; 0.166385
186	Skin - Sun Exposed (Lower leg)	GTEx	v8		0; 6.13265; 0.042041; 0.046424; 0.0191867; 0.0263476; 6.08561; 10.6461; 0.17262; 0.165815
187	Small Intestine - Terminal Ileum	GTEx	v8		0; 4.19378; 0.0354079; 0.0395775; 0.0433611; 0.0168076; 0.0302887; 4.68572; 8.38552; 0.112703
188	Spleen	GTEx	v8		0; 5.92631; 0.0363784; 0.0832374; 0.453602; 44.8999; 75.7844; 2.41364; 0.234036; 0.227098
189	Stomach	GTEx	v8		0; 3.06248; 0.0325904; 0.0471121; 0.0538492; 0.0166057; 0.025408; 3.60607; 6.30717; 0.10173
190	Testis	GTEx	v8		0.166403; 4.70253; 0; 0.0542228; 0.0535776; 0.0391763; 0.334056; 0.276834; 34.8944; 54.1281
191	Thyroid	GTEx	v8		0; 6.27255; 0.039058; 0.0486038; 0.0234676; 0.0578069; 9.50338; 16.2787; 0.449414; 0.211291
192	Uterus	GTEx	v8		0; 7.19001; 0.0163333; 0.0262654; 0.0394926; 4.14399; 6.71823; 0.169672; 0.034329; 12.6468
193	Vagina	GTEx	v8		0; 5.74554; 0.0274644; 0.0152188; 0.025248; 0.0718387; 8.72436; 14.5704; 0.233237; 0.209406
194	Whole Blood	GTEx	v8		0; 2.64743; 0.0964428; 0.795466; 134.312; 194.869; 6.70072; 0.274032; 0.266855; 5.12505
195	gene	GNOMADmetrics	v2.1.1		OR4F5; SAMD11; NOC2L; KLHL17; PLEKHN1; C1orf170; HES4; ISG15; AGRN; RNF223
196	transcript	GNOMADmetrics	v2.1.1		ENST00000335137; ENST00000342066; ENST00000327044; ENST00000338591; ENST00000379410; ENST00000433179; ENST00000428771; ENST00000379389; ENST00000379370; ENST00000453464
197	obs_mis	GNOMADmetrics	v2.1.1		67; 546; 577; 467; 480; 422; 103; 117; 1303; 124
198	exp_mis	GNOMADmetrics	v2.1.1		8.2715e+01; 3.6202e+02; 4.6201e+02; 4.3355e+02; 3.8117e+02; 3.9110e+02; 9.0430e+01; 1.1566e+02; 1.3261e+03; 1.0779e+02
199	oe_mis	GNOMADmetrics	v2.1.1		8.1001e-01; 1.5082e+00; 1.2489e+00; 1.0772e+00; 1.2593e+00; 1.0790e+00; 1.1390e+00; 1.0115e+00; 9.8257e-01; 1.1504e+00
200	mu_mis	GNOMADmetrics	v2.1.1		4.1668e-06; 2.0713e-05; 2.9346e-05; 3.1317e-05; 2.4060e-05; 2.4195e-05; 4.1431e-06; 8.0856e-06; 9.9464e-05; 7.7410e-06
201	possible_mis	GNOMADmetrics	v2.1.1		1978; 4156; 4856; 4083; 3802; 4345; 1473; 1057; 12779; 1522
202	obs_mis_pphen	GNOMADmetrics	v2.1.1		29; 132; 140; 167; 135; 110; 30; 31; 342; 12
203	exp_mis_pphen	GNOMADmetrics	v2.1.1		3.1909e+01; 9.0043e+01; 1.3562e+02; 1.7558e+02; 9.7727e+01; 9.7787e+01; 3.0382e+01; 3.1318e+01; 3.9487e+02; 2.1509e+01
204	oe_mis_pphen	GNOMADmetrics	v2.1.1		9.0884e-01; 1.4660e+00; 1.0323e+00; 9.5114e-01; 1.3814e+00; 1.1249e+00; 9.8741e-01; 9.8985e-01; 8.6611e-01; 5.5790e-01
205	possible_mis_pphen	GNOMADmetrics	v2.1.1		776; 1102; 1490; 1558; 1147; 1182; 389; 337; 3727; 407
206	obs_syn	GNOMADmetrics	v2.1.1		28; 270; 320; 360; 216; 215; 53; 63; 727; 58
207	exp_syn	GNOMADmetrics	v2.1.1		3.0512e+01; 1.5898e+02; 1.9938e+02; 2.0109e+02; 1.7452e+02; 1.7481e+02; 4.1769e+01; 5.8149e+01; 6.0335e+02; 5.0639e+01
208	oe_syn	GNOMADmetrics	v2.1.1		9.1766e-01; 1.6983e+00; 1.6049e+00; 1.7903e+00; 1.2377e+00; 1.2299e+00; 1.2689e+00; 1.0834e+00; 1.2049e+00; 1.1454e+00
209	mu_syn	GNOMADmetrics	v2.1.1		1.7760e-06; 9.2699e-06; 1.3672e-05; 1.6269e-05; 1.1429e-05; 1.2220e-05; 1.9868e-06; 4.4670e-06; 4.9630e-05; 3.7764e-06
210	possible_syn	GNOMADmetrics	v2.1.1		607; 1486; 1471; 1359; 1323; 1611; 588; 363; 4373; 579
211	obs_lof	GNOMADmetrics	v2.1.1		2; 22; 43; 26; 25; 21; 6; 0; 29; 7
212	mu_lof	GNOMADmetrics	v2.1.1		9.6530e-08; 1.3068e-06; 2.1537e-06; 1.6488e-06; 1.5693e-06; 1.0314e-06; 1.5251e-07; 4.7048e-08; 5.0007e-06; 9.0400e-08
213	possible_lof	GNOMADmetrics	v2.1.1		60; 285; 447; 292; 332; 204; 49; 12; 963; 38
214	exp_lof	GNOMADmetrics	v2.1.1		2.3369e+00; 2.4538e+01; 4.1785e+01; 2.8650e+01; 3.1069e+01; 1.7757e+01; 3.5300e+00; 1.1056e+00; 9.0870e+01; 2.1002e+00
215	pLI	GNOMADmetrics	v2.1.1		3.0354e-02; 4.7681e-14; 2.8933e-29; 1.3052e-16; 1.1549e-14; 1.1667e-15; 1.3746e-05; 4.0527e-01; 5.4727e-07; 2.6565e-02
216	pNull	GNOMADmetrics	v2.1.1		3.5740e-01; 9.4979e-01; 9.9995e-01; 9.7837e-01; 8.5111e-01; 9.9702e-01; 8.7001e-01; 1.1604e-01; 1.4068e-12; 3.8803e-01
217	pRec	GNOMADmetrics	v2.1.1		6.1225e-01; 5.0208e-02; 5.2786e-05; 2.1625e-02; 1.4889e-01; 2.9832e-03; 1.2998e-01; 4.7870e-01; 1.0000e+00; 5.8541e-01
218	oe_lof	GNOMADmetrics	v2.1.1		8.5584e-01; 8.9656e-01; 1.0291e+00; 9.0749e-01; 8.0467e-01; 1.1826e+00; 1.6997e+00; 0.0000e+00; 3.1914e-01; 9.5227e-01
219	oe_syn_lower	GNOMADmetrics	v2.1.1		6.7900e-01; 1.5370e+00; 1.4640e+00; 1.6410e+00; 1.1070e+00; 1.1000e+00; 1.0170e+00; 8.8400e-01; 1.1330e+00; 9.2600e-01
220	oe_syn_upper	GNOMADmetrics	v2.1.1		1.2580e+00; 1.8750e+00; 1.7610e+00; 1.9390e+00; 1.3850e+00; 1.3770e+00; 1.5950e+00; 1.3360e+00; 1.2810e+00; 1.4250e+00
221	oe_mis_lower	GNOMADmetrics	v2.1.1		6.6400e-01; 1.4050e+00; 1.1660e+00; 9.9800e-01; 1.1680e+00; 9.9600e-01; 9.7000e-01; 8.7000e-01; 9.3800e-01; 9.9400e-01
222	oe_mis_upper	GNOMADmetrics	v2.1.1		9.9300e-01; 1.6190e+00; 1.3380e+00; 1.1630e+00; 1.3580e+00; 1.1690e+00; 1.3420e+00; 1.1790e+00; 1.0290e+00; 1.3350e+00
223	oe_lof_lower	GNOMADmetrics	v2.1.1		3.2500e-01; 6.4000e-01; 8.0500e-01; 6.6400e-01; 5.8500e-01; 8.3700e-01; 8.1600e-01; 0.0000e+00; 2.3700e-01; 3.5200e-01
224	oe_lof_upper	GNOMADmetrics	v2.1.1		1.8400e+00; 1.2800e+00; 1.3270e+00; 1.2590e+00; 1.1240e+00; 1.6860e+00; 1.9470e+00; 1.6910e+00; 4.3500e-01; 1.8670e+00
225	constraint_flag	GNOMADmetrics	v2.1.1		mis_too_many|syn_outlier; syn_outlier; mis_too_many; no_exp_lof; mis_too_many|no_exp_lof; mis_too_many|no_exp_lof|syn_outlier; lof_too_many|mis_too_many; no_exp_lof|syn_outlier; no_variants; lof_too_many
226	syn_z	GNOMADmetrics	v2.1.1		3.5753e-01; -6.9212e+00; -6.7147e+00; -8.8090e+00; -2.4681e+00; -2.3898e+00; -1.3661e+00; -5.0008e-01; -3.9572e+00; -8.1312e-01
227	mis_z	GNOMADmetrics	v2.1.1		6.1403e-01; -3.4361e+00; -1.9010e+00; -5.7094e-01; -1.7988e+00; -5.5519e-01; -4.6973e-01; -4.4129e-02; 2.2552e-01; -5.5496e-01
228	lof_z	GNOMADmetrics	v2.1.1		2.0421e-01; 4.7484e-01; -1.7417e-01; 4.5884e-01; 1.0089e+00; -7.1321e-01; -1.2182e+00; 9.7435e-01; 6.0143e+00; 6.4099e-02
229	oe_lof_upper_rank	GNOMADmetrics	v2.1.1		17847; 13738; 14172; 13521; 12118; 16725; 18996; 16766; 4022; 18109
230	oe_lof_upper_bin	GNOMADmetrics	v2.1.1		9; 7; 6; 8; 2; 4; 1; 3; 5; NA
231	oe_lof_upper_bin_6	GNOMADmetrics	v2.1.1		5; 4; 3; 1; 2; NA; 0
232	n_sites	GNOMADmetrics	v2.1.1		0; 34; 70; 33; 50; 8; 45; 7; 29; 9
233	classic_caf	GNOMADmetrics	v2.1.1		0.0000e+00; 1.9574e-03; 8.1459e-04; 2.4370e-04; 8.7804e-04; 1.8299e-04; 2.7434e-04; 3.4378e-05; 2.5172e-03; 1.2909e-04
234	max_af	GNOMADmetrics	v2.1.1		0.0000e+00; 1.1243e-03; 1.8303e-04; 5.2832e-05; 2.5184e-04; 7.2816e-05; 3.3964e-05; 9.3434e-06; 1.6688e-03; 4.0444e-05
235	no_lofs	GNOMADmetrics	v2.1.1		0; 125204; 125546; 125310; 125455; 124573; 125566; 125216; 125180; 124996
236	obs_het_lof	GNOMADmetrics	v2.1.1		0; 446; 201; 60; 177; 44; 64; 8; 562; 32
237	obs_hom_lof	GNOMADmetrics	v2.1.1		0; 11; 1; 5; 6; 449; 4; NA; 7; 20
238	defined	GNOMADmetrics	v2.1.1		0; 125661; 125747; 125370; 125633; 124617; 125630; 125224; 125028; 124553
239	p	GNOMADmetrics	v2.1.1		0.0000e+00; 1.8200e-03; 7.9954e-04; 2.3932e-04; 7.0866e-04; 1.7656e-04; 2.5475e-04; 3.1943e-05; 2.2571e-03; 1.2798e-04
240	exp_hom_lof	GNOMADmetrics	v2.1.1		0.0000e+00; 4.1626e-01; 8.0386e-02; 7.1805e-03; 6.3093e-02; 3.8846e-03; 8.1530e-03; 1.2778e-04; 6.4060e-01; 2.0478e-03
241	classic_caf_afr	GNOMADmetrics	v2.1.1		0.0000e+00; 5.1398e-03; 6.8242e-04; 2.7152e-03; 1.3773e-04; 2.5951e-04; 7.0349e-03; 5.6840e-04; 1.2817e-04; 6.1652e-05
242	classic_caf_amr	GNOMADmetrics	v2.1.1		0.0000e+00; 1.4034e-03; 4.3436e-04; 2.3435e-04; 2.0908e-04; 8.8595e-05; 4.5574e-04; 1.2367e-04; 7.6515e-04; 2.9097e-05
243	classic_caf_asj	GNOMADmetrics	v2.1.1		0.0000e+00; 6.1387e-04; 4.2758e-03; 1.0898e-04; 4.1102e-04; 1.0428e-04; 5.1493e-04; 2.0421e-04; 9.9681e-05; 2.6499e-02
244	classic_caf_eas	GNOMADmetrics	v2.1.1		0.0000e+00; 8.4838e-03; 9.3132e-04; 2.1891e-04; 2.8479e-04; 1.1039e-03; 1.6640e-04; 2.1430e-02; 5.4807e-05; 1.0928e-04
245	classic_caf_fin	GNOMADmetrics	v2.1.1		0.0000e+00; 4.9778e-04; 4.6194e-05; 2.7009e-04; 9.9890e-05; 1.9800e-04; 1.9082e-03; 3.6979e-04; 1.5074e-02; 1.9856e-04
246	classic_caf_nfe	GNOMADmetrics	v2.1.1		0.0000e+00; 1.2324e-03; 8.3002e-04; 3.7926e-04; 5.8498e-04; 1.1713e-04; 3.2021e-04; 1.7989e-05; 6.2696e-04; 9.8368e-05
247	classic_caf_oth	GNOMADmetrics	v2.1.1		0.0000e+00; 1.6858e-03; 1.3339e-03; 1.6426e-04; 7.3836e-04; 1.6892e-04; 2.8384e-03; 2.0438e-03; 1.6502e-04; 3.3763e-04
248	classic_caf_sas	GNOMADmetrics	v2.1.1		0.0000e+00; 1.0732e-03; 5.0007e-04; 1.6406e-04; 2.8601e-03; 2.3060e-04; 1.3681e-04; 3.2678e-05; 2.4477e-04; 2.9418e-04
249	p_afr	GNOMADmetrics	v2.1.1		0.0000e+00; 4.8134e-03; 6.7690e-04; 2.5889e-03; 1.2583e-04; 2.4631e-04; 6.3563e-03; 5.5909e-04; 1.2532e-04; 6.1533e-05
250	p_amr	GNOMADmetrics	v2.1.1		0.0000e+00; 1.3309e-03; 4.3372e-04; 2.3135e-04; 2.0239e-04; 8.7112e-05; 4.3377e-04; 1.1577e-04; 7.2297e-04; 2.8931e-05
251	p_asj	GNOMADmetrics	v2.1.1		0.0000e+00; 5.9577e-04; 4.2750e-03; 9.9369e-05; 3.9730e-04; 1.0003e-04; 4.9883e-04; 1.9962e-04; 9.9310e-05; 2.6543e-02
252	p_eas	GNOMADmetrics	v2.1.1		0.0000e+00; 7.9700e-03; 9.2464e-04; 2.1758e-04; 2.7189e-04; 1.0457e-03; 1.6318e-04; 1.9434e-02; 5.4414e-05; 1.0874e-04
253	p_fin	GNOMADmetrics	v2.1.1		0.0000e+00; 4.6204e-04; 4.6195e-05; 2.3099e-04; 9.2855e-05; 1.8483e-04; 1.8032e-03; 3.6962e-04; 1.4427e-02; 1.8479e-04
254	p_nfe	GNOMADmetrics	v2.1.1		0.0000e+00; 1.1448e-03; 8.0019e-04; 3.7124e-04; 5.1078e-04; 1.1556e-04; 2.9940e-04; 1.7709e-05; 5.0115e-04; 9.7642e-05
255	p_oth	GNOMADmetrics	v2.1.1		0.0000e+00; 1.4678e-03; 1.3038e-03; 1.6341e-04; 6.5253e-04; 1.6352e-04; 2.6093e-03; 1.9672e-03; 1.6368e-04; 3.2696e-04
256	p_sas	GNOMADmetrics	v2.1.1		0.0000e+00; 1.0458e-03; 4.9006e-04; 1.6334e-04; 1.9944e-03; 2.2943e-04; 1.3067e-04; 3.2672e-05; 2.2866e-04; 2.9408e-04
257	transcript_type	GNOMADmetrics	v2.1.1		protein_coding
258	transcript_level	GNOMADmetrics	v2.1.1		2; 3; 1
259	cds_length	GNOMADmetrics	v2.1.1		915; 2043; 2247; 1926; 1833; 2088; 741; 495; 6135; 747
260	num_coding_exons	GNOMADmetrics	v2.1.1		1; 13; 19; 12; 16; 5; 3; 2; 36; 8
261	gene_type	GNOMADmetrics	v2.1.1		protein_coding; polymorphic_pseudogene
262	gene_length	GNOMADmetrics	v2.1.1		918; 19696; 15106; 5129; 9369; 6919; 1211; 1118; 35994; 3342
263	exac_pLI	GNOMADmetrics	v2.1.1		1.7633e-01; 1.3538e-10; 1.3304e-19; 2.5168e-07; 2.0197e-08; NA; 1.4794e-04; 9.8478e-03; 1.7335e-01; 9.0878e-02
264	exac_obs_lof	GNOMADmetrics	v2.1.1		1; 17; 29; 13; 15; NA; 5; 3; 2; 8
265	exac_exp_lof	GNOMADmetrics	v2.1.1		2.2177e+00; 2.0005e+01; 2.8884e+01; 1.8832e+01; 2.1150e+01; NA; 3.4895e+00; 3.5107e+00; 5.4417e+01; 4.3923e+00
266	exac_oe_lof	GNOMADmetrics	v2.1.1		4.5091e-01; 8.4979e-01; 1.0040e+00; 6.9030e-01; 7.0923e-01; NA; 1.4329e+00; 8.5454e-01; 2.3890e-01; 4.5534e-01
267	brain_expression	GNOMADmetrics	v2.1.1		NA
268	chrom	GNOMADmetrics	v2.1.1		1; 2; 3; 4; 5; 6; 7; X; 8; 9
269	spos	GNOMADmetrics	v2.1.1		11869; 14404; 17369; 29554; 30366; 34554; 52473; 57598; 65419; 89295
270	epos	GNOMADmetrics	v2.1.1		14409; 29570; 17436; 31109; 30503; 36081; 53312; 64116; 71585; 133723
271	Ensembl_TRS	ENSEMBLIDxref	v2.1.1		ENST00000641515|ENST00000335137; ENST00000426406|ENST00000426406; ENST00000332831|ENST00000332831; ENST00000420190|ENST00000437963|ENST00000342066|ENST00000341065|ENST00000455979|ENST00000618181|ENST00000622503|ENST00000618323|ENST00000616016|ENST00000618779|ENST00000616125|ENST00000620200|ENST00000617307; ENST00000327044; ENST00000338591|ENST00000466300|ENST00000622660; ENST00000379410|ENST00000379409|ENST00000379407|ENST00000491024; ENST00000341290|ENST00000433179; ENST00000428771|ENST00000304952|ENST00000484667; ENST00000624697|ENST00000624652|ENST00000649529
272	Ensembl_PRO	ENSEMBLIDxref	v2.1.1		ENSP00000493376|ENSP00000334393; ENSP00000409316|ENSP00000409316; ENSP00000329982|ENSP00000329982; ENSP00000411579|ENSP00000393181|ENSP00000342313|ENSP00000349216|ENSP00000412228|ENSP00000480870|ENSP00000482138|ENSP00000480678|ENSP00000478421|ENSP00000484256|ENSP00000484643|ENSP00000484820|ENSP00000482090; ENSP00000317992; ENSP00000343930|ENSP00000463694|ENSP00000479477; ENSP00000368720|ENSP00000368719|ENSP00000368717|ENSP00000462558; ENSP00000343864|ENSP00000414022; ENSP00000393198|ENSP00000304595|ENSP00000425085; ENSP00000485643|ENSP00000485313|ENSP00000496832
273	UniProtKB-ID	ENSEMBLIDxref	v2.1.1		A0A4Y7LJF4_HUMAN|A0A2U3U0J3_HUMAN|OR4F4_HUMAN|OR4F5_HUMAN; OR4E2_HUMAN|OR4F3_HUMAN|A0A0S2Z5W7_HUMAN|A0A126GV92_HUMAN; X5D9M6_HUMAN|A6PWC8_HUMAN|M9P977_HUMAN|Q5SV95_HUMAN|SAM10_HUMAN|SAM11_HUMAN|C9JZE8_HUMAN|H7BY14_HUMAN|F2WG57_HUMAN|H7C3J6_HUMAN|A0A087WW16_HUMAN|A0A087WXB3_HUMAN|A0A087WYH2_HUMAN|A0A087WYW1_HUMAN|A0A087WV57_HUMAN|A0A087WX24_HUMAN|Q4GMY9_HUMAN|I7G285_HUMAN|A0A087X1G6_HUMAN|A0A087X1J5_HUMAN|A0A087X1H5_HUMAN|A0A087X223_HUMAN|A0A087X0Q0_HUMAN|A0A087X2A3_HUMAN|A0A087WWQ4_HUMAN|A0A087WYU3_HUMAN; NOBOX_HUMAN|NOC2L_HUMAN; KLH15_HUMAN|KLH17_HUMAN|B4DWR6_HUMAN|J3QLT4_HUMAN|A0A0G2JL37_HUMAN|Q0VGE6_HUMAN; PKHM3_HUMAN|PKHN1_HUMAN|J3KSL1_HUMAN|J3KSM5_HUMAN; PERL_HUMAN|PERM1_HUMAN; E9LY07_HUMAN|E9PB28_HUMAN|HES3_HUMAN|HES4_HUMAN|D6RCM9_HUMAN|D6REB3_HUMAN; A0A096LNQ0_HUMAN|A0A096LPJ4_HUMAN|Q67AQ5_HUMAN|A0A096LNZ9_HUMAN|ISCU_HUMAN|ISG15_HUMAN; AGRG7_HUMAN|AGRIN_HUMAN|A0A494C0C1_HUMAN|A0A494C0G5_HUMAN|A0A484HK63_HUMAN|A0A494C1I6_HUMAN|A0A087WY58_HUMAN|A0A087X208_HUMAN
274	Gene_Name	ENSEMBLIDxref	v2.1.1		HLA-C|OR4F4; OR4E2|ACBD4; CNTNAP2|HLA-A|SAMD10|GPM6B|ATP6|MED25|PCDHGA3|ZMYND8|ATPase 6|SRGAP2B|ACAP2|FNDC11|LCE1E; NOBOX; KLHL15|AGER; PLEKHM3|MED24; LPO; HLA-A|HES3|RANBP3L; ZNF638|HLA-DPB1|ISCU; ADGRG7|WAC|RHD|NEK3
275	GI	ENSEMBLIDxref	v2.1.1		187952255|187950479|15293733|57528066|38372849|29537517|28798607|38372801|21928461|53828740; 38372663|28798571|15293747|21929052|1034562110|119943152|52421349|1034562112|1034562116|1034644538|74762307|1034562114|52627209|957951562|578831409|187950697|937627533; 608785744|429508238|1034622837|45501292|119595587|26392486|18129632|399227394|18999520|399227396|166215037|21620135|76881819|399227386|16549227|302376347|766945278|1150584521|381245398|71012625|385254832|766945236|399227440; 229463046|1034654098|333470751|3041859|23503106|13097693|157694511|7018409|317373580; 578837965|226442729|16552933|12697899|21739921|88909167|15929973|38194229|37791471|52783052|194377134|111493991|119576706; 122937347|223462685|34528693|18088745|172046173|767918095|160419245|71682157|237820624|119576703|71680623|12052979|1491741744|237820622; 1209685|231569458|119614880|76828079|40549418|148250017|76827298|32187529|187224|12643419|586830542|1034562655|34529498|1034562657|607344299|607344301|158563938|523545115; 320332336|216548627|66912172|74746514|15214449|10121150|119576700|10863967|34098717|311643801|530360364; 758099|37021637|1685102|313104118|15080288|987996593|38303902|11545707|24307953|56699456|62900736|14550514|306901|67463938|340780633|335892445|30583433|321159980|52001470|340780634|339961370|335892446|319443765|4826774|27362957|386837|112491366|119576699; 28195603|109731698|14041985|238859647|48428916|229462926|119600224|1947080|530360311|2988422|54873613|61218463|14043307|460018339|114152771|39795260|765826147|21706410|1476413402|38196963|53791229
276	UniRef100	ENSEMBLIDxref	v2.1.1		UniRef100_A0A4Y7LJF4|UniRef100_Q8NH21|UniRef100_Q96R69; UniRef100_Q8NGC2|UniRef100_Q6IEY1|UniRef100_A0A0S2Z5W7; UniRef100_X5D9M6|UniRef100_A6PWC8|UniRef100_A0A0S4XQV4|UniRef100_I7FV93|UniRef100_Q9BYL1|UniRef100_Q96NU1|UniRef100_A0A493TFJ9|UniRef100_H7BY14|UniRef100_F2WG57|UniRef100_Q96NU1-2|UniRef100_A0A087WW16|UniRef100_A0A087WXB3|UniRef100_A0A087WYH2|UniRef100_A0A087WYW1|UniRef100_A0A087WV57|UniRef100_A0A087WX24|UniRef100_Q4GMY9|UniRef100_I7G285|UniRef100_A0A087X1G6|UniRef100_A0A087X1J5|UniRef100_A0A087X1H5|UniRef100_A0A087X223|UniRef100_Q9BVV2|UniRef100_A0A087X2A3|UniRef100_A0A087WWQ4|UniRef100_A0A087WYU3; UniRef100_O60393|UniRef100_Q9Y3T9; UniRef100_Q96M94|UniRef100_Q6TDP4|UniRef100_B4DWR6|UniRef100_J3QLT4|UniRef100_A0A0G2JL37|UniRef100_Q0VGE6; UniRef100_Q6ZWE6|UniRef100_Q494U1|UniRef100_J3KSL1|UniRef100_Q494U1-2; UniRef100_P22079|UniRef100_Q5SV97; UniRef100_F2X608|UniRef100_E9PB28|UniRef100_Q5TGS1|UniRef100_Q9HCC6|UniRef100_D6RCM9|UniRef100_D6REB3; UniRef100_B4E187|UniRef100_P05161|UniRef100_S6B6Q1|UniRef100_Q9H1K1; UniRef100_Q96K78|UniRef100_O00468|UniRef100_Q9BTA9|UniRef100_A0A494C0G5|UniRef100_A0A484HK63|UniRef100_A0A494C1I6|UniRef100_A0A087WY58
277	UniRef90	ENSEMBLIDxref	v2.1.1		UniRef90_P30686|UniRef90_Q8NGA8; UniRef90_Q8NGC2|UniRef90_Q6IEY1|UniRef90_A0A2K5VRT4; UniRef90_X5D9M6|UniRef90_A6PWC8|UniRef90_Q95J06|UniRef90_Q96NU1|UniRef90_Q9BYL1|UniRef90_A0A493TFJ9|UniRef90_P00846|UniRef90_Q96NU1-2|UniRef90_A0A087WW16|UniRef90_A0A087WXB3|UniRef90_A0A087WYH2|UniRef90_A0A087WYW1|UniRef90_A0A087WV57|UniRef90_A0A087WX24|UniRef90_G3SA20|UniRef90_A0A087X1G6|UniRef90_G1SG54|UniRef90_A0A087X223|UniRef90_Q9BVV2|UniRef90_A0A087X2A3|UniRef90_A0A087WWQ4; UniRef90_O60393|UniRef90_Q9Y3T9; UniRef90_Q96M94|UniRef90_Q6TDP4|UniRef90_B4DWR6|UniRef90_J3QLT4|UniRef90_Q15109-6|UniRef90_F7ANQ0; UniRef90_Q8BM47|UniRef90_Q494U1|UniRef90_J3KSL1|UniRef90_Q494U1-2; UniRef90_P22079|UniRef90_Q5SV97; UniRef90_Q8WMB6|UniRef90_A0A2K5RL97|UniRef90_Q5TGS1|UniRef90_Q9HCC6|UniRef90_Q86VV4; UniRef90_B4E187|UniRef90_P05161|UniRef90_P04440|UniRef90_Q9H1K1; UniRef90_Q96K78|UniRef90_O00468|UniRef90_Q9BTA9|UniRef90_O00468-7|UniRef90_P18577|UniRef90_P51956
278	UniRef50	ENSEMBLIDxref	v2.1.1		UniRef50_P17693|UniRef50_Q8NGA8; UniRef50_Q8NGC2|UniRef50_Q6IEY1|UniRef50_Q8NC06-3; UniRef50_A0A2K6PQG9|UniRef50_A0A2U3Z6A0|UniRef50_Q95J06|UniRef50_Q96NU1|UniRef50_Q9BYL1|UniRef50_A0A493TFJ9|UniRef50_P00846|UniRef50_Q1RNF8|UniRef50_A0A2K5RHT8|UniRef50_G1PAJ8|UniRef50_A0A087WYH2|UniRef50_M3YQW4|UniRef50_A0A087WV57|UniRef50_A0A087X2A3|UniRef50_G3SA20|UniRef50_A0A087X1G6|UniRef50_Q15057|UniRef50_A0A2K5ZXK5|UniRef50_Q9BVV2|UniRef50_Q5TA76; UniRef50_O60393|UniRef50_Q9Y3T9; UniRef50_Q96M94|UniRef50_Q6TDP4|UniRef50_B4DWR6|UniRef50_J3QLT4|UniRef50_Q15109; UniRef50_Q8BM47|UniRef50_Q494U1|UniRef50_J3KSL1; UniRef50_P22079|UniRef50_Q5SV97; UniRef50_A0A2K5LIZ5|UniRef50_Q9HCC6|UniRef50_Q5TGS1|UniRef50_Q6PDH4; UniRef50_B4E187|UniRef50_P05161|UniRef50_P04440|UniRef50_Q9H1K1; UniRef50_Q96K78|UniRef50_O00468|UniRef50_Q9BTA9|UniRef50_P18577|UniRef50_P51956
279	UniParc	ENSEMBLIDxref	v2.1.1		UPI001163D9C4|UPI000D1938F0|UPI0000041E1E|UPI0000041BC1; UPI0000041D88|UPI0000041D3C|UPI000387CF9A; UPI00044374A9|UPI0007E52A82|UPI0002D212D4|UPI000155D47B|UPI000012860F|UPI0000D61E04|UPI0001B7917F|UPI000155D47A|UPI000201D341|UPI000155D479|UPI0002065210|UPI0004E4CAA9|UPI00046209A0|UPI0004E4CA1D|UPI0001AE65FD|UPI0004E4C9EB|UPI00005620B6|UPI000277615B|UPI000462093F|UPI0004E4CB24|UPI0004E4CC2E|UPI0004E4CACB|UPI00053BD5C8|UPI0004E4C86A|UPI0004E4C96E|UPI0004E4CD21; UPI00019B220C|UPI00019B220B|UPI000041820C; UPI000019832F|UPI00001DFBF0|UPI00017A8154|UPI000268AE1E|UPI000215117A|UPI0000DBE19F; UPI000166304A|UPI0000DBEE58|UPI00002377C5|UPI00001416D8|UPI000268B00E|UPI000268AE1F; UPI0000131631|UPI0001A4717E|UPI0003E30FA7; UPI0001CF2A0F|UPI0001881B51|UPI000047096C|UPI000006EC19|UPI0001D3B176|UPI0001D3BBEE; UPI0004F2367C|UPI0004F23698|UPI0000089275|UPI00053BD5BA|UPI000021CA9A|UPI000007018B|UPI0000048D70; UPI000004B6DF|UPI000387D73E|UPI001088D15F|UPI0010872C9B|UPI0010BB94D6|UPI000387B6E0|UPI0004620DA5|UPI0004E4CB7F
280	EMBL	ENSEMBLIDxref	v2.1.1		LT989888|AL627309|L78442|BC136907|BC136908|AF399574|BK004223|AB065592; AB065895|AF399581|BK004526|AL732372|BC137547|BK004481|KU178780|KP290153; KJ535069|AL645608|JQ797332|AL118506|BC067362|JX093066|JX093070|JX093071|AK054643|BC024295|BC033213|AC003035|AC003037|HM852815|AC006942|AC018766|KC877749|AC005618|AC008781|KC877131|AL022342|AL031666|KF456929|KF456930|JQ703741|JQ797915|KP317047|KP317050|KY409340|AP008478|JX093093|AC242498|FP700111|AC090018|AC091633|AC126170|AL121829|AL353779; AC004534|AL050019|AL645608|BC003555; AK057298|BC015415|BC109058|BC109059|AB051464|AL834313|AY423763|AL645608|AK301650|CR812478|CR933878|BC105742|CH471183; AC083900|AC096772|BC020812|BC151137|AK123204|AL136730|AL645608|CH471183|BC101386|BC101387|AC090844|AC102799; U39573|EF579964|AY324876|AC004687|AC005962|BC107166|BC107167|M58151|KF150175|AK123855|AL645608|BC006300; HQ154163|AL645608|AL031847|AB048791|BC012351|AC008807|AC114277|KC876975; AC007878|AC096569|AC104084|AC109343|AL645608|AY375804|AY009127|AY009128|AC008119|BC011906|BC061903|U47101|M13755|M21786|AY168648|BT007297|CH471183|BC009507; AY181246|AK027360|CH471052|BC113451|AB191264|AL645608|AF016903|U84406|BC004220|BC007649|BC034009|BC063620|AL161936|AL358234|LR214928|AL139082|KF459684
281	EMBL-CDS	ENSEMBLIDxref	v2.1.1		SPI37852.1|AAI36908.1|AAI36909.1|AAK95059.1|DAA04621.1|BAC05820.1; BAC06111.1|AAK95066.1|DAA04924.1|AAI37548.1|DAA04879.1|ALQ34238.1|ALI87340.1; AHW56708.1|AFZ93926.1|AAH67362.1|AFP36417.1|AFP36421.1|AFP36422.1|BAB70781.1|AAH24295.1|AAH33213.1|ADL30666.1|AFF86596.1|AFI51648.1|AJT36220.1|AJT36259.1|AQU30835.1|BAE10202.1|AFP36444.1; AAC12957.1|CAB43240.2|AAH03555.1; BAB71415.1|AAH15415.1|AAI09059.1|AAI09060.1|BAB21768.1|CAD38983.1|AAR03710.1|BAG63128.1|AAI05743.1|EAW56302.1; AAH20812.1|AAI51138.1|BAC85557.1|CAB66664.1|EAW56299.1|AAI01387.1|AAI01388.1; AAC50717.1|ABQ53140.1|AAP72968.1|AAI07167.1|AAI07168.1|AAA63213.1|AGQ48858.1|BAC85711.1|AAH06300.1; ADW24281.1|BAB13510.1|AAH12351.1; AAQ88063.1|AAG37427.1|AAG37428.1|AAH11906.1|AAH61903.1|AAC50885.1|AAA36038.1|AAA36128.1|AAN86983.1|AAP35961.1|EAW56295.1|AAH09507.1; AAO27358.1|BAB55061.1|EAW79818.1|AAI13452.1|BAD52440.1|AAC39776.1|AAB52917.1|AAH04220.2|AAH07649.1|AAH34009.1|AAH63620.1|VEU33313.1
282	NCBI_TaxID	ENSEMBLIDxref	v2.1.1		9606
283	CCDS	ENSEMBLIDxref	v2.1.1		CCDS32343.1; CCDS41916.1; CCDS13549.1; CCDS47736.2; CCDS35217.1; CCDS42808.1; CCDS32689.1|CCDS54149.1; CCDS41238.1; CCDS44966.1|CCDS9118.1; CCDS2938.1
284	RefSeq	ENSEMBLIDxref	v2.1.1		NP_001004195.2|NP_001005484.1; NP_001005221.2|NP_001005224.1|NP_001005277.1|XP_016857897.1|XP_016857898.1|XP_016857899.1|XP_016857900.1|XP_016864827.1|XP_006722148.1; NP_542188.1|XP_016883160.1|NP_689699.2; NP_001073882.3|XP_016867231.1|NP_056473.2; NP_085127.2|XP_006724581.1|NP_938073.1; NP_001073944.1|XP_011509462.1|NP_001153656.1|NP_115505.2; NP_001153574.1|NP_006142.1|NP_001278295.1|NP_001278296.1|XP_016858072.1|XP_016858073.1; NP_001135939.1|NP_001019769.1|NP_066993.1|XP_005244828.1; NP_001306971.1|NP_055116.1|NP_998760.1|NP_005092.1; NP_116176.2|NP_001292204.1|NP_940978.2|XP_005244806.1
285	RefSeq_NT	ENSEMBLIDxref	v2.1.1		NM_001004195.2; XM_006722085.2; NM_080621.4|XM_017027671.1; NM_001080413.3|XM_017011742.1; NM_030624.2|XM_006724518.1; NM_001080475.2|XM_011511160.2; NM_001160102.1|NM_006151.2; NM_001024598.3; NM_001320042.1|NM_014301.4|NM_213595.3; NM_032787.2
286	PDB	ENSEMBLIDxref	v2.1.1		6HRL:A|6HRL:B; 5KZ5|5WKP|5WLW|6NZU|1Z2M:A|2HJ8:A|3PHX:B|3PSE:B|3R66:C|3R66:D|3RT3:B|3SDL:C|3SDL:D|5TL6:A|5TL6:C|5W8T:B|5W8T:D|5W8U:B|5W8U:D|6BI8:C|6BI8:D|6FFA:B; 2X9E|2ZMC|2ZMD|3CEK|3DBQ|3GFW|3H9F|3HMN|3HMO|3HMP|3VQU|3W1F|3WYX|3WYY|3WZJ|3WZK|4B94|4BHZ|4BI0|4BI1|4BI2|4C4E|4C4F|4C4G|4C4H|4C4I|4C4J|4CV8|4CV9|4CVA|4D2S|4H7X|4H7Y|4JS8|4JT3|4O6L|4ZEG|5AP0|5AP1|5AP2|5AP3|5AP4|5AP5|5AP6|5AP7|5EH0|5EHL|5EHO|5EHY|5EI2|5EI6|5EI8|5LJJ|5MRB|5N7V|5N84|5N87|5N93|5N9S|5NA0|5NAD|5NTT|5O91|6B4W|6GVJ|6H3K|6N6O; 1OQD|1XU2|2KN1|4ZFO|6J7W; 1RF3|4MXW|1D0A:G|1D0A:H|1D0A:I|1D0A:J|1D0A:K|1D0A:L|2HEV:R|2HEY:R|2HEY:T|6OGX:G|6OKM:R|6OKN:E|6OKN:R; 1UPK|1UPL|2WTK|3GNI|4FZA|4FZD|4FZF|4NZW|4O27; 2F4W:A|2F4W:B; 6BQN; 6IF3; 5KKP
287	BioGrid	ENSEMBLIDxref	v2.1.1		126661; 123224; 132958; 110207; 117038; 124318; 569148; 113123; 107080; 110233
288	DIP	ENSEMBLIDxref	v2.1.1		DIP-39616N; DIP-40642N; DIP-2928N; DIP-31316N; DIP-45598N; DIP-34063N; DIP-33194N; DIP-169N; DIP-31674N; DIP-61029N
289	MINT	ENSEMBLIDxref	v2.1.1		Q9H1K1; P33981; P36941; Q9Y376; Q9Y385; P51168; P23786; P84157; Q9UK58; P49406
290	STRING	ENSEMBLIDxref	v2.1.1		9606.ENSP00000317482; 9606.ENSP00000386195; 9606.ENSP00000358902; 9606.ENSP00000419457; 9606.ENSP00000332791; 9606.ENSP00000417003; 9606.ENSP00000262290; 9606.ENSP00000367130; 9606.ENSP00000310623; 9606.ENSP00000273352
291	ChEMBL	ENSEMBLIDxref	v2.1.1		CHEMBL5898; CHEMBL3983; CHEMBL1250360; CHEMBL3885534; CHEMBL2321635; CHEMBL2107836; CHEMBL3238; CHEMBL1613741; CHEMBL2176775; CHEMBL5416
292	DrugBank	ENSEMBLIDxref	v2.1.1		DB01782|DB12010; DB00594|DB14509|DB00384; DB00583|DB01074; DB00168|DB02772; DB00786; DB00142|DB00130; DB00659|DB00546|DB00404|DB00543|DB11901|DB11859|DB01558|DB00237|DB00241|DB00475|DB01594|DB00349|DB01068|DB00628|DB01559|DB01189|DB00829|DB00228|DB01215|DB00402|DB00898|DB00189|DB00292|DB01567|DB01205|DB01544|DB00690|DB06716|DB01437|DB00801|DB01159|DB00753|DB00602|DB00555|DB00431|DB00186|DB01043|DB00371|DB00463|DB01028|DB01107|DB12458|DB01595|DB00842|DB00312|DB00592|DB01708|DB01588|DB00794|DB00818|DB01589|DB01236|DB09118|DB00306|DB01956|DB00231|DB11582|DB00273|DB00897; DB04522|DB12010|DB02482|DB02010|DB00675; DB00042; DB08870|DB06324
293	BioMuta	ENSEMBLIDxref	v2.1.1		OR4F4; OR4E2; SAMD10; NOBOX; KLHL15; PLEKHM3; LPO; HES3; ISCU; ADGRG7
294	DMDM	ENSEMBLIDxref	v2.1.1		38372849; 38372663; 26392486; 88909167; 172046173; 12643419; 74746514; 313104118; 229462926; 160112977
295	CPTAC	ENSEMBLIDxref	v2.1.1		CPTAC-2234; CPTAC-1370; CPTAC-1171|CPTAC-1193; CPTAC-204|CPTAC-205; CPTAC-552; non-CPTAC-2682; CPTAC-1786; CPTAC-794|CPTAC-795; CPTAC-138|CPTAC-139; CPTAC-1313
296	ProteomicsDB	ENSEMBLIDxref	v2.1.1		77933; 73472; 79666|12390; 49389|49390; 77318; 68476|68477|68478; 16955|53957; 65128|13941; 80422|80423; 77050
297	DNASU	ENSEMBLIDxref	v2.1.1		26686; 135935; 389072; 23479; 84873; 93190; 7272; 608; 4055; 6908
298	GeneID	ENSEMBLIDxref	v2.1.1		26682|79501; 26683|729759|81399|79777; 140700|148398; 135935|26155; 80311|339451; 389072|84069; 4025|84808; 57801|390992; 23479|9636; 84873|375790
299	KEGG	ENSEMBLIDxref	v2.1.1		hsa:26682; hsa:140700; hsa:135935; hsa:80311; hsa:389072; hsa:4025; hsa:390992; hsa:23479; hsa:84873; hsa:643904
300	EuPathDB	ENSEMBLIDxref	v2.1.1		HostDB:ENSG00000177693.3; HostDB:ENSG00000221977.1; HostDB:ENSG00000130590.13|HostDB:ENSG00000046653.14|HostDB:ENSG00000104973.14|HostDB:ENSG00000254245.2|HostDB:ENSG00000101040.19|HostDB:ENSG00000196369.10|HostDB:ENSG00000114331.13|HostDB:ENSG00000125531.6|HostDB:ENSG00000186226.8; HostDB:ENSG00000106410.14; HostDB:ENSG00000174010.9; HostDB:ENSG00000178385.13|HostDB:ENSG00000008838.17; HostDB:ENSG00000167419.10; HostDB:ENSG00000173673.7|HostDB:ENSG00000164188.8; HostDB:ENSG00000075292.18|HostDB:ENSG00000136003.15; HostDB:ENSG00000144820.7|HostDB:ENSG00000136098.16
301	GeneCards	ENSEMBLIDxref	v2.1.1		OR4F4; OR4E2; SAMD10; NOBOX; KLHL15; PLEKHM3; LPO; HES3; ISCU; ADGRG7
302	HGNC	ENSEMBLIDxref	v2.1.1		HGNC:8301; HGNC:8297; HGNC:16129|HGNC:4461|HGNC:28845|HGNC:8701|HGNC:9397|HGNC:35237|HGNC:16469|HGNC:28764|HGNC:29466; HGNC:22448; HGNC:29347|HGNC:320; HGNC:34006|HGNC:22963; HGNC:6678; HGNC:26226|HGNC:26353; HGNC:17894|HGNC:29882; HGNC:19241|HGNC:17327|HGNC:7746
303	HPA	ENSEMBLIDxref	v2.1.1		HPA040973; HPA065730; HPA035046; HPA028688; HPA047927|HPA072697; CAB006329|HPA038602|HPA057592; HPA048916; HPA028396; CAB010166|CAB013229; CAB026202|HPA061617
304	MIM	ENSEMBLIDxref	v2.1.1		610934|611548|610770; 300980|300982; 150205|170990|615921; 609971|608060; 255125|611911|147571|616126; 612307|103320|615120; 604092; 109545|603905; 600979|600315|615593; 612174|614282
305	neXtProt	ENSEMBLIDxref	v2.1.1		NX_Q96R69; NX_Q8NGC2; NX_Q9BYL1; NX_O60393; NX_Q96M94; NX_Q6ZWE6; NX_P22079; NX_Q5TGS1; NX_Q9H1K1; NX_Q96K78
306	PharmGKB	ENSEMBLIDxref	v2.1.1		PA32290; PA32278; PA25678; PA134934728; PA162399738; PA30439; PA142671692; PA162392328; PA134982718; PA164725453
307	eggNOG	ENSEMBLIDxref	v2.1.1		ENOG410J9XX|ENOG411192Y; ENOG410IVIK|ENOG410YB9C; KOG3516|ENOG410XPHG|ENOG410IJ7W|ENOG41128Z9|KOG4800|ENOG4110EPW|KOG4665|COG0356|ENOG410IHD9|ENOG410Z0HI|KOG3594|ENOG410XQHI|ENOG410ITRI|ENOG410XSDA|KOG3565|ENOG410XS44|KOG0521|COG5347|ENOG410IGYC|ENOG410YC0Q; KOG0490|ENOG410YIJ3; KOG4441|ENOG410XNX8; KOG1829|ENOG410ZMB5|ENOG410IF72|ENOG410YPDT; KOG2408|ENOG410XPZ3; ENOG410INMI|ENOG4112CPE; ENOG410IN3N|ENOG4111GCE|ENOG410IWG3|ENOG410YI0S|KOG3361|COG0822; KOG4193|ENOG410XSD2
308	GeneTree	ENSEMBLIDxref	v2.1.1		ENSGT00940000162706; ENSGT00390000008161|ENSGT00390000006915|ENSGT00940000160439|ENSGT00940000164906|ENSGT00940000154897|ENSGT00950000182824|ENSGT00940000156389|ENSGT00390000006008|ENSGT00950000183301; ENSGT00650000093445; ENSGT00940000159116; ENSGT00940000159743|ENSGT00390000016438; ENSGT00940000160488; ENSGT00730000111482|ENSGT00940000161387; ENSGT00940000153322|ENSGT00390000015813; ENSGT00940000159169|ENSGT00440000037780|ENSGT00940000159738; ENSGT00390000002856
309	HOGENOM	ENSEMBLIDxref	v2.1.1		HOG000041362; HOG000132938; HOG000113810; HOG000231204|HOG000234617; HOG000090264; HOG000016084; HOG000236346|HOG000290662; HOG000069228; HOG000236310; HOG000137599
310	KO	ENSEMBLIDxref	v2.1.1		K04257; K10452; K12550; K09088; K22068; K08464; K08866; K05153; K03159; K08272|K03120
311	OMA	ENSEMBLIDxref	v2.1.1		LRKWDVH; AENIPCH; FCPQALG; DQNKIHL; CNMFELS; RCRDHGM; VWRPWSP; SMVTEMV; DYRQEEI; TRSFCCR
312	OrthoDB	ENSEMBLIDxref	v2.1.1		958833at2759; 1010638at2759|1546859at2759; 1252828at2759; 729946at2759; 250404at2759; 177737at2759; 276568at2759; 1095795at2759; 1406557at2759; 349194at2759
313	TreeFam	ENSEMBLIDxref	v2.1.1		TF337251; TF325918; TF337576; TF328485; TF317067; TF314316; TF351373; TF105422; TF351485; TF333220
314	Reactome	ENSEMBLIDxref	v2.1.1		R-HSA-381753; R-HSA-8941413; R-HSA-1362409; R-HSA-5669034; R-HSA-5668541|R-HSA-5676594; R-HSA-380972|R-HSA-6798695; R-HSA-9037629; R-HSA-983168; R-HSA-2672351; R-HSA-6782315
315	ChiTaRS	ENSEMBLIDxref	v2.1.1		ACBD4; CNTNAP2|HLA-A|SAMD10|GPM6B|ATP6|MED25|ZMYND8|DNAH8|SRGAP2B|ACAP2; KLHL15|AGER; PLEKHM3|MED24; LPO; HLA-A; ZNF638|HLA-DPB1|ISCU; ADGRG7|WAC|RHD|NEK3; SEC24C|TTYH2|SLC38A11|HLA-B|XRN1|PPP4R1|PRR5|HLA-DRB1; TNFRSF17|SECTM1
316	GeneWiki	ENSEMBLIDxref	v2.1.1		NOBOX; Lactoperoxidase; ISCU; TTK_(gene); TNFRSF17; Lymphotoxin_beta_receptor; CAB39; B3GALT5; UBE2J1; SCNN1B
317	GenomeRNAi	ENSEMBLIDxref	v2.1.1		26682; 79777; 140700; 135935; 80311; 389072; 4025; 390992; 23479; 84873
318	CRC64	ENSEMBLIDxref	v2.1.1		399A0675E540C86D|903D4D8E98EA07F6; 59A922BBA6978452|E3241CE48D9E9081; B4CE79C106B91FB8|C32A8E01834CB2E2|DF2678F090A3E946|7CE2E149F1BB821A|DC6D801F30E7E862|9EB7BBFA85047C9E|8A9D02F98EBA61E1|48DC72597BCEBEC9|AF7628CF46E8E4D5|6D2D9F98DEA4F3A3|50EF59FB1911CFDC|1EAACA0EC8CBAC49|3252BCA9CB0C405B; 02ED17B02018A89C; E37606E8AE367C83|7A857C0E39686356|36C93FA1BDFB557F; 53A2BCF3580CAE14|03B8544D835BD239; BC7AA410997198C0; FDB69EB6D9F3D02C|F64A0949CBB0654D|FF9F1830502644D4; 6B58A6E8CDE8C538|91F414FC4C703D26|0166D3EC9F1EEB47; D6CAAA78AC0E4679|11C008F6987D75B3|5A346304644B0BB4|CAB3F77DD187A266
319	UniProtID	ENSEMBLIDxref	v2.1.1		A0A2U3U0J3|Q8NH21; Q6IEY1|A0A126GV92; A6PWC8|Q5SV95|Q96NU1|H7BY14|H7C3J6|A0A087WXB3|A0A087WYW1|A0A087WX24|I7G285|A0A087X1J5|A0A087X223|A0A087X2A3|A0A087WYU3; Q9Y3T9; Q6TDP4|J3QLT4|Q0VGE6; Q494U1|Q494U1|Q494U1|J3KSM5; Q5SV97|Q5SV97; E9PB28|Q9HCC6|D6REB3; A0A096LPJ4|A0A096LNZ9|P05161; O00468|A0A494C0G5|A0A494C1I6|A0A087X208
320	GO	ENSEMBLIDxref	v2.1.1		GO:0016021|GO:0005886|GO:0004930|GO:0004984|GO:0007186; GO:0003677|GO:0005634; GO:0005829|GO:0030690|GO:0030691|GO:0005730|GO:0005654|GO:0005634|GO:0003682|GO:0042393|GO:0031491|GO:0070491|GO:0003723|GO:0003714|GO:0006915|GO:0034644|GO:0031497|GO:0002903|GO:0035067|GO:2001243|GO:0000122|GO:1901796|GO:0042273; GO:0015629|GO:0030054|GO:0032839|GO:0005615|GO:0043025|GO:0014069|GO:0045211|GO:0051015|GO:0060090|GO:0031208|GO:0030036|GO:0007420|GO:0016567; GO:0005856|GO:0031966|GO:0005739|GO:0005886|GO:1901612|GO:0070300|GO:1901981|GO:0001786|GO:0061158|GO:0043065|GO:0001666; GO:0005737|GO:0005634|GO:0006355|GO:0014850; GO:0005634|GO:0003677|GO:0046983|GO:0006355|GO:0000790|GO:0000981|GO:0001227|GO:0070888|GO:0071820|GO:0000977|GO:0008134|GO:0009952|GO:0030154|GO:0045665|GO:0000122; GO:0005737|GO:0005829|GO:0005576|GO:0005654|GO:0005634|GO:0005178|GO:0031386|GO:0031625|GO:0042742|GO:0051607|GO:0007229|GO:0072643|GO:0072608|GO:0032020|GO:0019941|GO:0031397|GO:0032480|GO:0045071|GO:0030501|GO:0045648|GO:0032649|GO:0034340|GO:0019985|GO:0060337|GO:0016032; GO:0005604|GO:0030054|GO:0062023|GO:0005829|GO:0070062|GO:0005576|GO:0005796|GO:0016021|GO:0043202|GO:0005886|GO:0045202|GO:0005509|GO:0035374|GO:0002162|GO:0043395|GO:0043236|GO:0033691|GO:0005200|GO:0009887|GO:0045162|GO:0016358|GO:0030198|GO:0007213|GO:0006024|GO:0006027|GO:0008045|GO:0007528|GO:0051491|GO:0043547|GO:0045887|GO:0045944|GO:0043113|GO:0001523|GO:0007165|GO:0050808|GO:0009888; GO:0016021|GO:0046872
321	PIR	ENSEMBLIDxref	v2.1.1		A28304; I37552; I39196; A38282|B54024|E54024|F54024|H54024|T09568; B54024|E54024|F54024|H54024; A24853; JN0877; S06053; T00334; T00364
322	UCSC	ENSEMBLIDxref	v2.1.1		uc002cdf.2; uc010tmd.2; uc002yhm.2|uc064ybm.1|uc061bkf.1|uc063ial.1|uc061xnr.1|uc057jzk.1|uc062rqq.1|uc061ynl.1|uc057lak.1; uc022aoj.1; uc002vcl.3|uc060ewh.1; uc002ivt.3; uc009vly.2|uc063czv.1; uc061kmm.1|uc001tnc.5; uc003duc.5|uc058xgf.1; uc010vuy.2
323	Orphanet	ENSEMBLIDxref	v2.1.1		619; 43115; 171876|60033|526; 263524|228302|228308|228305; 496790; 54260; 157769|101063; 853; 64280|2382|106; 84064
324	Gene_Synonym	ENSEMBLIDxref	v2.1.1		C20orf136|ATP6; KIAA1677; DAPR|PLEKHM1L; SAPX; BHLHB43; NIFUN; GPR128; MPS1|MPS1L1; BCM|BCMA; D12S370|TNFCR|TNFR3|TNFRSF3
325	ComplexPortal	ENSEMBLIDxref	v2.1.1		CPX-2188|CPX-312|CPX-313; CPX-341|CPX-344|CPX-346|CPX-348; CPX-419; CPX-341|CPX-343|CPX-344|CPX-347; CPX-2164|CPX-2166|CPX-2167|CPX-2168|CPX-2174|CPX-2951|CPX-2954; CPX-1195; CPX-880|CPX-922; CPX-696; CPX-3219|CPX-3220; CPX-1004|CPX-900|CPX-903|CPX-989|CPX-997
326	TCDB	ENSEMBLIDxref	v2.1.1		1.A.6.1.1; 9.A.14.7.4; 2.A.7.9.9; 1.A.9.5.4; 8.A.5.1.1; 1.A.47.1.1; 1.F.1.1.1; 2.A.1.44.3; 9.B.82.1.2; 2.A.1.1.88
327	BioCyc	ENSEMBLIDxref	v2.1.1		MetaCyc:MONOMER-20081; MetaCyc:HS08187-MONOMER; MetaCyc:HS10587-MONOMER; MetaCyc:HS11014-MONOMER; MetaCyc:HS04372-MONOMER; MetaCyc:ENSG00000168288-MONOMER; MetaCyc:HS08467-MONOMER; MetaCyc:HS00644-MONOMER; MetaCyc:HS05981-MONOMER; MetaCyc:HS04051-MONOMER
328	GeneReviews	ENSEMBLIDxref	v2.1.1		ISCU; CPT2; GABRB3; SKIV2L; MMADHC; WRN; NPHP3; KIF1A; PEX13; CLCN5
329	SwissLipids	ENSEMBLIDxref	v2.1.1		SLP:000000792|SLP:000000844; SLP:000001044; SLP:000001931; SLP:000000940; SLP:000001071; SLP:000001526; SLP:000001553; SLP:000000652; SLP:000000140; SLP:000001082
330	UniPathway	ENSEMBLIDxref	v2.1.1		UPA00143; UPA00378; UPA00659; UPA00253|UPA00705; UPA00241|UPA00705; UPA00705; UPA00109; UPA00115; UPA00220; UPA00534
331	Gene_ORFName	ENSEMBLIDxref	v2.1.1		hCG_19035; CGI-66|hCG_2029691|hCG_20419; CGI-76|HSPC153|HSPC205|hCG_15053; hCG_1645842|hCG_16055; BM-001|UNQ530/PRO1073; hCG_27621; hCG_33132; PSEC0038; hCG_1992246; hCG_23298
332	GlyConnect	ENSEMBLIDxref	v2.1.1		1855; 795; 1981; 1488; 1919; 773; 1525; 1224; 625; 1608
333	DisProt	ENSEMBLIDxref	v2.1.1		DP00443; DP00173; DP00090; DP00069; DP01450; DP00492; DP01131; DP00321; DP01518; DP01420
334	GuidetoPHARMACOLOGY	ENSEMBLIDxref	v2.1.1		2264; 739; 2720; 412; 1488; 1877; 624; 2154; 1232; 628
335	MEROPS	ENSEMBLIDxref	v2.1.1		P02.020; M10.026; I39.006; S01.132; S01.152; S01.155; C14.009; A28.003; M16.974; C85.004
336	ESTHER	ENSEMBLIDxref	v2.1.1		human-ABHD6; human-AADACL3; human-AADACL2; human-ABHD18; human-SERAC1; human-LYPLA1; human-NDRG4; human-PLA2G15; human-EPHX1; human-PRCP
337	Allergome	ENSEMBLIDxref	v2.1.1		11040; 2121; 1064; 9614; 8213; 11858; 8363; 3322|411; 9621; 11697
338	PeroxiBase	ENSEMBLIDxref	v2.1.1		3316; 3605; 4448; 3320; 5398|5827; 4426; 3355; 3606; 3601; 3604|3629
339	REBASE	ENSEMBLIDxref	v2.1.1		1161|4240; 12076; 4636; 4119; 4120
340	PATRIC	ENSEMBLIDxref	v2.1.1		fig|1028802.3.peg.20; fig|1028802.3.peg.1826
341	GeneDB	ENSEMBLIDxref	v2.1.1		Smp_196150.1:pep
